<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6456224</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0211756</article-id><article-id pub-id-type="publisher-id">PONE-D-19-01781</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Parasitology</subject><subj-group><subject>Parasite Groups</subject><subj-group><subject>Apicomplexa</subject><subj-group><subject>Plasmodium</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Biomarkers</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Database and Informatics Methods</subject><subj-group><subject>Bioinformatics</subject><subj-group><subject>Sequence Analysis</subject><subj-group><subject>Sequence Motif Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Eukaryota</subject><subj-group><subject>Protozoans</subject><subj-group><subject>Parasitic Protozoans</subject><subj-group><subject>Malarial Parasites</subject><subj-group><subject>Plasmodium Falciparum</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Parasitic Diseases</subject><subj-group><subject>Malaria</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Tropical Diseases</subject><subj-group><subject>Malaria</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene Expression</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Molecular Biology</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Artificial Gene Amplification and Extension</subject><subj-group><subject>Polymerase Chain Reaction</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Artificial Gene Amplification and Extension</subject><subj-group><subject>Polymerase Chain Reaction</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>DNA aptamers for the recognition of HMGB1 from Plasmodium falciparum </plain></SENT>
</text></SecTag></article-title><alt-title alt-title-type="running-head">Aptamers for HMGB1 from <italic>Plasmodium falciparum</italic></alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6295-2117</contrib-id><name><surname>Joseph</surname><given-names>Diego F.</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing – original draft</role><role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nakamoto</surname><given-names>Jose A.</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Software</role><role content-type="http://credit.casrai.org/">Visualization</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Garcia Ruiz</surname><given-names>Oscar Andree</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing – original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Peñaranda</surname><given-names>Katherin</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Visualization</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sanchez-Castro</surname><given-names>Ana Elena</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Visualization</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Castillo</surname><given-names>Pablo Soriano</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6679-5473</contrib-id><name><surname>Milón</surname><given-names>Pohl</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Visualization</role><role content-type="http://credit.casrai.org/">Writing – original draft</role><role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Laboratory of Applied Biophysics and Biochemistry, Centre for Research and Innovation, Health Sciences Faculty, Universidad Peruana de Ciencias Aplicadas (UPC), Lima, Perú</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Research and Innovation Division, BDM, Lima, Perú</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Snounou</surname><given-names>Georges</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Université Pierre et Marie Curie, FRANCE</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><text><SENT sid="1" pm="."><plain>Competing Interests: BDM is a Startup of the Laboratory of Applied Biophysics and Biochemistry (UPC) where PM owns shares. </plain></SENT>
<SENT sid="2" pm="."><plain>BDM is funded by the Peruvian government (136-2016-Fondecyt) and is committed to develop diagnostic methods for neglected diseases. </plain></SENT>
<SENT sid="3" pm="."><plain>This does not alter our adherence to PLOS ONE policies on sharing data and materials. </plain></SENT>
</text></p></fn><corresp id="cor001">* E-mail: <email>pmilon@upc.edu.pe</email></corresp></author-notes><pub-date pub-type="epub"><day>9</day><month>4</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>14</volume><issue>4</issue><elocation-id>e0211756</elocation-id><history><date date-type="received"><day>18</day><month>1</month><year>2019</year></date><date date-type="accepted"><day>24</day><month>3</month><year>2019</year></date></history><permissions><copyright-statement>© 2019 Joseph et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Joseph et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0211756.pdf"/><abstract><p><SecTag type="ABS"><text><SENT sid="4" pm="."><plain>Rapid Diagnostic Tests (RDTs) for malaria are restricted to a few biomarkers and antibody-mediated detection. </plain></SENT>
<SENT sid="5" pm="."><plain>However, the expression of commonly used biomarkers varies geographically and the sensibility of immunodetection can be affected by batch-to-batch differences or limited thermal stability. </plain></SENT>
<SENT sid="6" pm="."><plain>In this study we aimed to overcome these limitations by identifying a potential biomarker and by developing molecular sensors based on aptamer technology. </plain></SENT>
<SENT sid="7" pm="."><plain>Using gene expression databases, ribosome profiling analysis, and structural modeling, we find that the High Mobility Group Box 1 protein (HMGB1) of Plasmodium falciparum is highly expressed, structurally stable, and present along all blood-stages of P. falciparum infection. </plain></SENT>
<SENT sid="8" pm="."><plain>To develop biosensors, we used in vitro evolution techniques to produce DNA aptamers for the recombinantly expressed HMG-box, the conserved domain of HMGB1. </plain></SENT>
<SENT sid="9" pm="."><plain>An evolutionary approach for evaluating the dynamics of aptamer populations suggested three predominant aptamer motifs. </plain></SENT>
<SENT sid="10" pm="."><plain>Representatives of the aptamer families were tested for binding parameters to the HMG-box domain using microscale thermophoresis and rapid kinetics. </plain></SENT>
<SENT sid="11" pm="."><plain>Dissociation constants of the aptamers varied over two orders of magnitude between nano- and micromolar ranges while the aptamer-HMG-box interaction occurred in a few seconds. </plain></SENT>
<SENT sid="12" pm="."><plain>The specificity of aptamer binding to the HMG-box of P. falciparum compared to its human homolog depended on pH conditions. </plain></SENT>
<SENT sid="13" pm="."><plain>Altogether, our study proposes HMGB1 as a candidate biomarker and a set of sensing aptamers that can be further developed into rapid diagnostic tests for P. falciparum detection. </plain></SENT>
</text></SecTag></p></abstract><funding-group><award-group id="award001"><funding-source><institution>Grand Challenges Canada (CA)</institution></funding-source><award-id>0692-01-10</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6679-5473</contrib-id><name><surname>Milón</surname><given-names>Pohl</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution>Fondecyt</institution></funding-source><award-id>038-2014-Fondecyt</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6679-5473</contrib-id><name><surname>Milón</surname><given-names>Pohl</given-names></name></principal-award-recipient></award-group><award-group id="award003"><funding-source><institution>Fondecyt</institution></funding-source><award-id>136-2016-Fondecyt</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6679-5473</contrib-id><name><surname>Milón</surname><given-names>Pohl</given-names></name></principal-award-recipient></award-group><award-group id="award004"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100010750</institution-id><institution>InnóvatePerú</institution></institution-wrap></funding-source><award-id>297-INNOVATEPERU-EC-2016</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6679-5473</contrib-id><name><surname>Milón</surname><given-names>Pohl</given-names></name></principal-award-recipient></award-group><funding-statement>This work was funded by grants from Grand Challenges Canada, 0692-01-10 (<ext-link ext-link-type="uri" xlink:href="https://www.grandchallenges.ca/">https://www.grandchallenges.ca/</ext-link>), Fondecyt, 038-2014-Fondecyt and 136-2016-Fondecyt (<ext-link ext-link-type="uri" xlink:href="http://www.fondecyt.gob.pe/">http://www.fondecyt.gob.pe/</ext-link>), and InnóvatePerú. 297-INNOVATEPERU-EC-2016 (<ext-link ext-link-type="uri" xlink:href="http://www.innovateperu.gob.pe/">http://www.innovateperu.gob.pe/</ext-link>) to PM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="5"/><table-count count="1"/><page-count count="20"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the manuscript and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the manuscript and its Supporting Information files.</p></notes></front><body><SecTag type="INTRO"><sec sec-type="intro" id="sec001"><title><text><SENT sid="14" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="15" pm="."><plain>Malaria is an infectious disease that affects animals and humans, caused by protozoans of the genus Plasmodium. </plain></SENT>
<SENT sid="16" pm="."><plain>Malaria remains the cause of 435,000 deaths worldwide, with 219 million cases reported during 2017 [1]. </plain></SENT>
<SENT sid="17" pm="."><plain>Accurate treatment requires the identification of the parasite of the genus Plasmodium, in addition to the species causing the disease. </plain></SENT>
<SENT sid="18" pm="."><plain>Currently, there are several methods to diagnose malaria, such as PCR-based, Giemsa microscopy, and Rapid Diagnostic Tests (RDTs). </plain></SENT>
<SENT sid="19" pm="."><plain>Among these options, the last two appear to be suitable for low-income and mostly affected countries; nonetheless, they also present certain limitations [2]. </plain></SENT>
</text></p><p><text><SENT sid="20" pm="."><plain>Giemsa microscopy is inexpensive to perform, can differentiate malaria species and stages, and can quantify the parasites [2]. </plain></SENT>
<SENT sid="21" pm="."><plain>However, well-trained personnel is required and, frequently unavailable in low-income countries [2]. </plain></SENT>
<SENT sid="22" pm="."><plain>RDTs, on the other hand, detect Plasmodium spp. biomarker antigens in a small amount of blood using immobilized antibodies. </plain></SENT>
<SENT sid="23" pm="."><plain>The two most used biomarkers are histidine-rich protein 2 (HRP-2) and lactate dehydrogenase (LDH), which have been shown of high sensitivity and specificity for detecting P. falciparum [3]. </plain></SENT>
<SENT sid="24" pm="."><plain>However, P. falciparum strains lacking the HRP-2 and HRP-3 genes have appeared, increasing false negative results [4,5]. </plain></SENT>
<SENT sid="25" pm="."><plain>Furthermore, PfLDH has a maximum peak of expression at 24 to 30 hours in the intraerythrocytic cycle but decreases to a minimum in the schizont stage. </plain></SENT>
<SENT sid="26" pm="."><plain>On the other hand, HRP-2 is exclusively synthesized during P. falciparum asexual erythrocytic development (reviewed in [6]). </plain></SENT>
<SENT sid="27" pm="."><plain>Using biomarkers that are present longer in the blood stages of P. falciparum can be advantageous to increase the sensibility of infection detection. </plain></SENT>
</text></p><p><text><SENT sid="28" pm="."><plain>Additionally, the production of sensing antibodies requires advanced facilities to ensure both, reproducibility and consistency between batches. </plain></SENT>
<SENT sid="29" pm="."><plain>This limitation is aggravated by delivery logistics to the final user where transportation and temperature conditions affect the efficiency, sensibility, and specificity of RDTs. </plain></SENT>
<SENT sid="30" pm="."><plain>Although RDTs continue being the best alternative for rapid screening and detection of malaria in low-income countries, they require novel biomarkers for Plasmodium spp. to overcome the detection of false negatives and the development of sensing molecules that are more reproducible and thermostable. </plain></SENT>
</text></p><p><text><SENT sid="31" pm="."><plain>Recent genomic, transcriptomic, and proteomic studies of Plasmodium spp. are a great source to identify potential new and abundant biomarkers [7–9]. </plain></SENT>
<SENT sid="32" pm="."><plain>In this context, ribosome profiling (RP) appears to fill the gap between transcriptomics and proteomics [10]. </plain></SENT>
<SENT sid="33" pm="."><plain>RP evaluates mRNA expression and estimates the ribosomal load for each particular mRNA [10]. </plain></SENT>
<SENT sid="34" pm="."><plain>Thus, RP allows the researcher to identify which genes are expressed at any given conditions and, at the same time, RP estimates the relative protein abundance potential. </plain></SENT>
<SENT sid="35" pm="."><plain>In the context of biomarker discovery, RP arrives as a valid alternative to identify proteins that are highly synthesized in the cell. </plain></SENT>
</text></p><p><text><SENT sid="36" pm="."><plain>Aptamers offer a valid alternative for the development of biosensors as they overcome such immunogenic requirement of antibodies [11]. </plain></SENT>
<SENT sid="37" pm="."><plain>Additionally, aptamers are chemically synthetized which leads to the substantial reduction of variability between production batches [11]. </plain></SENT>
<SENT sid="38" pm="."><plain>Aptamers, identified through Systematic Evolution of Ligands by Exponential enrichment (SELEX) [12,13], have shown additional and significant advantages over antibodies without compromising binding and biochemical specificity parameters [11]. </plain></SENT>
<SENT sid="39" pm="."><plain>Aptamers for malaria detection have been successfully developed for the commonly used biomarkers HRP-2 and LDH [14–17]. </plain></SENT>
<SENT sid="40" pm="."><plain>Here, we use gene expression databases and recent RP reports to identify a potential new biomarker for the detection Plasmodium spp., recombinantly produce it to purity, and develop high-affinity aptamers as biosensors. </plain></SENT>
<SENT sid="41" pm="."><plain>Altogether, our study proposes a novel biomarker and a set of biosensors that can further be developed into RDTs for Plasmodium spp. detection. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="materials|methods" id="sec002"><title><text><SENT sid="42" pm="."><plain>Material and methods </plain></SENT>
</text></title><sec id="sec003"><title><text><SENT sid="43" pm="."><plain>Biomarker selection </plain></SENT>
</text></title><p><text><SENT sid="44" pm="."><plain>Translational gene expression regulation, as assessed by RP on asexual blood stages, were primarily used to identify highly translated mRNAs [9]. </plain></SENT>
<SENT sid="45" pm="."><plain>RNA-seq on all blood stages of P. falciparum were compared using PlasmoDB search tools [9,18,19]. </plain></SENT>
<SENT sid="46" pm="."><plain>Genes whose transcription was homogenous and constant among all blood stages of P. falciparum were selected. </plain></SENT>
<SENT sid="47" pm="."><plain>The corresponding proteins were probed for the availability of three-dimensional structures or the potential to be predicted. </plain></SENT>
<SENT sid="48" pm="."><plain>Proteins without atomic resolution or predicted structures were excluded as available structural reports show that aptamers bind to tertiary folds of proteins [20]. </plain></SENT>
<SENT sid="49" pm="."><plain>Protein stability and solubility, as well as the presence of transmembrane domains, were estimated using the ExPASy ProtParam tool (Swiss Institute of Bioinformatics, Switzerland) and TMHMM 2.0 (Center for Biological Sequence Analysis, Technical University of Denmark, DK). </plain></SENT>
<SENT sid="50" pm="."><plain>The human homolog of HMGB1 was used for negative selection steps. </plain></SENT>
<SENT sid="51" pm="."><plain>HMGB1 contains the HMG-box, which is a conserved domain among eukaryotes [21]. </plain></SENT>
<SENT sid="52" pm="."><plain>Both conserved domains, from Plasmodium falciparum or Homo sapiens, are subsequently going to be called HMG-box Pf and HMG-box Hs, respectively. </plain></SENT>
<SENT sid="53" pm="."><plain>Clustal Omega (EMBL-EBI, UK) was used to compare HMG-box Pf and HMG-box Hs by multiple sequence alignment analysis between these two domains [22]. </plain></SENT>
</text></p></sec><sec id="sec004"><title><text><SENT sid="54" pm="."><plain>Oligonucleotides, cloning, expression, and purification of HMG-box domain </plain></SENT>
</text></title><p><text><SENT sid="55" pm="."><plain>Oligonucleotides, unmodified or chemically modified with fluorescein, were synthesized by Macrogen (Korea). </plain></SENT>
<SENT sid="56" pm="."><plain>DNA sequences coding for HMG-box Pf and Hs were cloned into the plasmid pET-24c (+) (KanR) by GenScript (USA). </plain></SENT>
<SENT sid="57" pm="."><plain>The coding sequences of both domains were optimized for codon usage of the host (E. coli BL21) using OptimumGene (GenScript, USA) and a His-Tag was added at the carboxyl end for further purification. E. coli BL21 (DE3) were made competent and transformed using Mix &amp; Go E. coli Transformation Kit &amp; Buffer Set (Zymo Research, USA). </plain></SENT>
<SENT sid="58" pm="."><plain>Transformed E. coli were cultured in Terrific Broth (yeast extract 24 g/L, tryptone 20 g/L, KH2PO4 0.017 M, K2HPO4 0.072 M) medium at 37°C until the absorbance at 600 nm reached 0.5. </plain></SENT>
<SENT sid="59" pm="."><plain>Then, Isopropyl β-D-1-thiogalactopyranoside (IPTG) 1 mM was added to induce protein expression and incubation continued for three hours. </plain></SENT>
<SENT sid="60" pm="."><plain>After incubation, the culture was centrifuged at 6,000 g for 20 min at 4°C. </plain></SENT>
<SENT sid="61" pm="."><plain>Then, the supernatant was discarded, and the pellet was resuspended using HAKM10 Buffer (50 mM HEPES (pH 7.4), 70 mM ammonium acetate, 30 mM NaCl, 10 mM MgCl2, 6 mM 2-mercaptoethanol). </plain></SENT>
<SENT sid="62" pm="."><plain>Cells were pelleted again before lysis with using 5 mL BugBuster Master Mix (EMD Millipore, USA) for each gram of cells. </plain></SENT>
<SENT sid="63" pm="."><plain>After resuspension and incubation at room temperature for 20 minutes, the lysate was centrifuged at 12,000 g for 40 min at 4°C. </plain></SENT>
<SENT sid="64" pm="."><plain>The supernatant was collected for purification using a 1 mL His Trap FF Crude Column containing Ni-NTA (GE Healthcare, USA). </plain></SENT>
<SENT sid="65" pm="."><plain>Briefly, the column was equilibrated using five volumes of His-Tag Buffer with 10 mM imidazole (20 mM sodium phosphate (pH 7.4), 0.5 M NaCl). </plain></SENT>
<SENT sid="66" pm="."><plain>Then, the collected supernatant was loaded into the column followed by three volumes of His-Tag Buffer containing 30 mM imidazole to remove nonspecific bound proteins. </plain></SENT>
<SENT sid="67" pm="."><plain>Finally, HMG-box was eluted with five volumes of His-Tag Buffer containing 300 mM imidazole. </plain></SENT>
<SENT sid="68" pm="."><plain>1 mL fractions were collected independently and analyzed by SDS-PAGE electrophoresis (18% acrylamide) and Coomassie blue staining. </plain></SENT>
<SENT sid="69" pm="."><plain>Eluted proteins were dialyzed using a 3 kDa membrane D-Tube Dialyzer (Merck, Germany) to remove the imidazole in Storage Buffer (200 mM ammonium acetate, 50 mM HEPES, 6 mM 2-Mercaptoethanol, 10% glycerol, pH 7.1). </plain></SENT>
<SENT sid="70" pm="."><plain>Protein purity was assessed by (18% acrylamide) SDS-PAGE electrophoresis and Coomassie blue staining. </plain></SENT>
</text></p></sec><sec id="sec005"><title><text><SENT sid="71" pm="."><plain>Protein labeling </plain></SENT>
</text></title><p><text><SENT sid="72" pm="."><plain>HMG-box Pf and Hs preparations were labeled with NHS-Biotin for SELEX rounds or with NHS-Atto540Q essentially as described in [23]. </plain></SENT>
<SENT sid="73" pm="."><plain>Protein preparations were dialyzed using NHS Labeling Buffer (200 mM NaCl, 50 mM HEPES, 6 mM 2-Mercaptoethanol, 5% Glycerol, pH 7.8) to remove primary amines. </plain></SENT>
<SENT sid="74" pm="."><plain>Labeling reactions were performed using a 2:1 label to protein ratio. </plain></SENT>
<SENT sid="75" pm="."><plain>Reactions were incubated with moderated stirring at room temperature for 1 hour. </plain></SENT>
<SENT sid="76" pm="."><plain>After incubation, non-protein-bound labels were quenched using Glycine in a final concentration of 25 mM. </plain></SENT>
<SENT sid="77" pm="."><plain>Labeled proteins were purified using His Trap FF Crude Column containing Ni-NTA (as described above) and dialyzed in Storage Buffer. </plain></SENT>
</text></p></sec><sec id="sec006"><title><text><SENT sid="78" pm="."><plain>SELEX </plain></SENT>
</text></title><p><text><SENT sid="79" pm="."><plain>SELEX was performed using a 40-mer ssDNA random library (Trilink Biotechnologies, USA) which contained constant flanking regions: 5’ TAG GGA AGA GAA GGA CAT ATG AT (N40) TTG ACT AGT ACA TGA CCA CTT GA 3’. </plain></SENT>
<SENT sid="80" pm="."><plain>Amplification primers were: forward (5’ TAG GGA AGA GAA GGA CAT ATG AT 3’) and reverse (5’ TCA AGT GGT CAT GTA CTA GTC AA 3’). </plain></SENT>
<SENT sid="81" pm="."><plain>For transcription-mediated amplification of libraries, a T7 promoter sequence was added (T7 reverse primer: 5’ TTC AGG TAA TAC GAC TCA CTA TAG GGT CAA GTG GTC ATG TAC TAG TCA A 3’). </plain></SENT>
<SENT sid="82" pm="."><plain>Each selection round was composed of: i) Aptamer selection using biotinylated HGM-box that were immobilized on streptavidin-coated magnetic beads (Streptavidin Mag Sepharose from GE Healthcare, USA). </plain></SENT>
<SENT sid="83" pm="."><plain>The bead binding capacity for either HMG-box Pf or HMG-box Hs was estimated to19 pmol/μL beads slurry. </plain></SENT>
<SENT sid="84" pm="."><plain>Selections were performed in SELEX Buffer (100 mM NaCl, 1.5 mM KCl, 5 mM MgCl2, 6mM 2-Mercaptoethanol, 50 mM Tris HCl, pH 7.5) at 25°C with moderate and continuous shaking. </plain></SENT>
<SENT sid="85" pm="."><plain>ii) HGM-box-bound aptamers were separated from the solution using a magnet followed by resuspension using SELEX buffer and a second magnetic separation. </plain></SENT>
<SENT sid="86" pm="."><plain>The number of bead resuspensions (washes) varied along SELEX rounds (S2 Table). </plain></SENT>
<SENT sid="87" pm="."><plain>iii) Bound oligonucleotides were used for further regeneration of the ssDNA library by PCR using Trilink forward, and T7 Trilink-modified reverse primers using the Maxima Hot Start Green PCR Master Mix (2X) (Thermo Fisher Scientific, USA). </plain></SENT>
<SENT sid="88" pm="."><plain>iv) Resulting dsDNA were used for in vitro transcription using the TranscriptAid T7 High Yield Transcription Kit (Thermo Fisher Scientific, USA). </plain></SENT>
<SENT sid="89" pm="."><plain>v) in vitro reverse transcription was used to regenerate a ssDNA pool of enriched aptamers using the RevertAid Reverse transcriptase (Thermo Fisher Scientific, USA). </plain></SENT>
<SENT sid="90" pm="."><plain>Generally, the selection stringency was increased along cycles of SELEX by modifying ionic strength, time of incubation and the number of washes (S2 Table). </plain></SENT>
<SENT sid="91" pm="."><plain>Purity and size of dsDNA, RNA, and ssDNA was assessed by 8M UREA PAGE followed by methylene blue staining. </plain></SENT>
<SENT sid="92" pm="."><plain>Concentration was measured by absorbance at 260 nm in a Nanodrop One spectrophotometer (Thermo Fisher Scientific, USA). </plain></SENT>
</text></p></sec><sec id="sec007"><title><text><SENT sid="93" pm="."><plain>Diversity Visualization by Endonuclease (DiVE) assay and library enrichment </plain></SENT>
</text></title><p><text><SENT sid="94" pm="."><plain>DiVE protocol was standardized based on Lim et al. [24]. </plain></SENT>
<SENT sid="95" pm="."><plain>All the experiments were performed using the Thermo Scientific S1 endonuclease (Thermo Fisher Scientific, USA). </plain></SENT>
<SENT sid="96" pm="."><plain>For the reaction tubes, 200 ng of double-stranded DNA (dsDNA) from each SELEX cycle was used. </plain></SENT>
<SENT sid="97" pm="."><plain>The final volume of the reaction was 20 μL, and each sample contained S1 Reaction Buffer (40 mM sodium acetate (pH 4.5), 300 mM NaCl, 2 mM ZnSO4). </plain></SENT>
<SENT sid="98" pm="."><plain>Each tube reaction was subjected to denaturation at 95°C for 5 minutes and reannealing at 65°C for 5 minutes. </plain></SENT>
<SENT sid="99" pm="."><plain>After that, 1 μL of S1 endonuclease U/μL was added to the mixture followed by 30 minutes incubation at 65°C. </plain></SENT>
<SENT sid="100" pm="."><plain>Reactions were stopped by adding ethylene- diaminetetraacetic acid (EDTA) to a final concentration of 2 mM (pH 8.0). </plain></SENT>
<SENT sid="101" pm="."><plain>Finally, 5μL of each sample was mixed with 1 μL of RunSafe (Cleaver Scientific, UK) and visualized in a 2% agarose gel. </plain></SENT>
<SENT sid="102" pm="."><plain>Low diversity samples appeared as defined bands of the expected DNA length while high diversity samples appeared as smears or were absent. </plain></SENT>
</text></p></sec><sec id="sec008"><title><text><SENT sid="103" pm="."><plain>Library sequencing </plain></SENT>
</text></title><p><text><SENT sid="104" pm="."><plain>Cycles four, six, eight, ten, and fourteen were taken for Next Generation Sequencing as they showed low (cycle four), partial (cycles six and eight) and high (cycles ten and fourteen) enrichment as evaluated by DiVE. </plain></SENT>
<SENT sid="105" pm="."><plain>The dsDNA pools were processed as described in the 16S Metagenomic Sequencing Library Preparation protocol (Illumina, USA). </plain></SENT>
<SENT sid="106" pm="."><plain>Briefly, 5 ng of dsDNA from each selected cycle was amplified by PCR for eight cycles using forward (5’ TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA CAG TAG GGA AGA GAA GGA CAT ATG AT 3’) and reverse (5’ GTC TCG TGG GCT CGG AGA TGT GTA TAA GAG ACA GTC AAG TGG TCA TGT ACT AGT CAA 3’) Trilink primers modified with overhang adapters. </plain></SENT>
<SENT sid="107" pm="."><plain>After amplification, PCR products were purified with the AMPure XP beads (Beckman Coulter, USA) protocol. </plain></SENT>
<SENT sid="108" pm="."><plain>Subsequently, sequencing indexes were added by PCR, provided by the Nextera XT Index Kit (Illumina, USA). </plain></SENT>
<SENT sid="109" pm="."><plain>Finally, indexed PCR products were purified with AMPure XP beads (Ampure, USA). </plain></SENT>
<SENT sid="110" pm="."><plain>Each indexed PCR product was quantified by absorbance at 260 nm and diluted to a final concentration of 4 nM using 10 mM Tris (pH 8.5). </plain></SENT>
<SENT sid="111" pm="."><plain>Five microliters of each indexed PCR were mixed to obtain the pooled library. </plain></SENT>
<SENT sid="112" pm="."><plain>Finally, the pooled library was denatured using an equal volume of 0.2 N NaOH, incubated and room temperature for 5 minutes and diluted again to a final concentration of 4 pM using HT1 Buffer (Illumina, USA) and loaded into the MiSeq Reagent Nano Kit v2 cartridge (Illumina, USA) for 300 reading cycles. </plain></SENT>
</text></p></sec><sec id="sec009"><title><text><SENT sid="113" pm="."><plain>Bioinformatic analysis and aptamer selection </plain></SENT>
</text></title><p><text><SENT sid="114" pm="."><plain>For a primary analysis of the sequences and a comparison between SELEX cycles, the bioinformatic toolkit FASTAptamer was employed [25]. </plain></SENT>
<SENT sid="115" pm="."><plain>Reverse data retrieved by sequencing was reverse complemented and mixed with the forward data to obtain a collection of sequences comprising both sequencing steps. </plain></SENT>
<SENT sid="116" pm="."><plain>The FASTAptamer Count command allowed to estimate the frequency for all sequences in each SELEX cycle. </plain></SENT>
<SENT sid="117" pm="."><plain>Subsequently, the FASTAptamer Enrich command was used to estimate the relative increase in abundance between subsequent SELEX cycles for each sequence analyzed. </plain></SENT>
<SENT sid="118" pm="."><plain>Candidate molecules were ranked depending on the enrichment between cycles and abundance. </plain></SENT>
<SENT sid="119" pm="."><plain>The MEME Suite and Clustal Omega (EMBL-EBI) was used to evaluate the presence of conserved motifs [22,26]. </plain></SENT>
<SENT sid="120" pm="."><plain>Mfold was used to determine the Gibbs free energy of potential secondary structures using the selection conditions, 25°C, 100 mM Na+, and 3 mM Mg+2 [27]. </plain></SENT>
<SENT sid="121" pm="."><plain>Conserved flanking regions of the aptamer library were included in the analysis. </plain></SENT>
</text></p></sec><sec id="sec010"><title><text><SENT sid="122" pm="."><plain>Three-dimensional structure modeling and docking predictions </plain></SENT>
</text></title><p><text><SENT sid="123" pm="."><plain>Modeling of three-dimensional (3D) structures of aptamers followed the principles described by Jeddi et al. [28]. </plain></SENT>
<SENT sid="124" pm="."><plain>Briefly, the Mfold web server was employed to predict secondary structures of the aptamers as described above. </plain></SENT>
<SENT sid="125" pm="."><plain>Output files were saved using the Vienna bracket format [27]. </plain></SENT>
<SENT sid="126" pm="."><plain>A 3D equivalent single-stranded RNA (ssRNA) model was built for each aptamer through the RNAComposer web server, using the bracket structures previously obtained [29]. </plain></SENT>
<SENT sid="127" pm="."><plain>The 3D ssRNA models were manually transformed into ssDNA structures using the molefacture and the autoPSF plugin of VMD software [30]. </plain></SENT>
<SENT sid="128" pm="."><plain>This was achieved by replacing the H5 atom in each uracil residue with a methyl moiety, manually replacing the uracil denomination with thymine in the PDB file, and changing the ribose to deoxyribose with the autoPSF builder [28]. </plain></SENT>
<SENT sid="129" pm="."><plain>Then, we used VMD and NAMD to refine the new 3D DNA structures in an ionized (100 mM NaCl) water box through 10,000 iterations of energy minimization [31,32]. </plain></SENT>
<SENT sid="130" pm="."><plain>The 3D structure of HMG-box Pf was built using homology modeling with the SWISS-MODEL Suit ([33]. </plain></SENT>
<SENT sid="131" pm="."><plain>Finally, the ZDOCK server was employed to predict the structural interaction between the aptamers and the HMG-box Pf [34]. </plain></SENT>
<SENT sid="132" pm="."><plain>We used the ZDOCK server with ZDOCK 3.0.2 without specifying specific interactions. </plain></SENT>
</text></p></sec><sec id="sec011"><title><text><SENT sid="133" pm="."><plain>Determination of dissociation constants </plain></SENT>
</text></title><p><text><SENT sid="134" pm="."><plain>Dissociation constants were measured using Microscale Thermophoresis (MST) on a Monolith NT.115 instrument (NanoTemper, Germany). </plain></SENT>
<SENT sid="135" pm="."><plain>Thermal migrations were monitored in real time by using a FAM-labeled probe (probeFAM) annealed to the 5' end of the aptamer. </plain></SENT>
<SENT sid="136" pm="."><plain>Pre-annealing of the probe to the aptamer was performed by mixing aptamers with probeFAM in 4:1 ratio followed by 5 min denaturation at 95°C and 20 min renaturation at room temperature. </plain></SENT>
<SENT sid="137" pm="."><plain>Reactions (20 μL) were prepared containing 50 nM of aptamers and varying concentrations of either HMG-box Pf or Hs. </plain></SENT>
<SENT sid="138" pm="."><plain>Before measuring, samples were centrifuged at 14,000 g for 5 min. </plain></SENT>
<SENT sid="139" pm="."><plain>The reactions were loaded into MO-K022 standard capillaries (NanoTemper, Germany) and measured. </plain></SENT>
<SENT sid="140" pm="."><plain>A preliminary fluorescence scan of capillaries was used to assess homogeneity within the titration. </plain></SENT>
<SENT sid="141" pm="."><plain>Reactions were excluded if a fluorescence difference between scans was higher than 10%. </plain></SENT>
<SENT sid="142" pm="."><plain>Time courses of fluorescence measurements were set 5 seconds with the infrared (IR) laser off, 30 seconds with the IR on, and 5 seconds off. </plain></SENT>
<SENT sid="143" pm="."><plain>A delay of 25 seconds between reads was used for thermal equilibration of the instrument. </plain></SENT>
<SENT sid="144" pm="."><plain>All reactions were performed in PBS at room temperature. </plain></SENT>
<SENT sid="145" pm="."><plain>IR laser power was set to 20% while fluorescence excitation power was set to 20% to 70% according to the dynamic of each aptamer. </plain></SENT>
</text></p></sec><sec id="sec012"><title><text><SENT sid="146" pm="."><plain>Kinetic experiments </plain></SENT>
</text></title><p><text><SENT sid="147" pm="."><plain>To measure the kinetics of aptamer-protein interactions an SX20 stopped-flow apparatus was used (Applied Photophysics, UK). </plain></SENT>
<SENT sid="148" pm="."><plain>All reactions were performed in SELEX Buffer (pH 7.4). </plain></SENT>
<SENT sid="149" pm="."><plain>Aptamers, PfR6 and PfE3, were pre-annealed to the probeFAM as described above and called from herein, PfR6FAM and PfE3FAM. </plain></SENT>
<SENT sid="150" pm="."><plain>Fluorescent measurements were carried out at 22 ˚C using a monochromatic light source (470 nm) powered with 10 mA. </plain></SENT>
<SENT sid="151" pm="."><plain>Emitted fluorescence was measured with photomultipliers set at 320 V after passing a long-pass filter with a cut-off of 515 nm essentially as described in [35]. </plain></SENT>
<SENT sid="152" pm="."><plain>Equal volumes (60 μL) of each reactant were rapidly mixed and fluorescence changes over time were measured. </plain></SENT>
<SENT sid="153" pm="."><plain>Typically, one solution contained aptamer (0.25 μM), probeFAM (0.2 μM) while the second solution was composed of 1 μM HMG-box540Q Pf or Hs, quenching derivatives of their respective proteins labeled with Atto-540Q. </plain></SENT>
<SENT sid="154" pm="."><plain>Between 7 to 10 replicates were measured. </plain></SENT>
<SENT sid="155" pm="."><plain>Every single measurement acquired 1,000 data points in a logarithmic sampling mode. </plain></SENT>
<SENT sid="156" pm="."><plain>Apparent rate constants were estimated by non-linear regression with exponential equations using Prism 7.02 (Graphpad Sofware, USA). </plain></SENT>
<SENT sid="157" pm="."><plain>Averaged rate constants were calculated as described in [36]. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec sec-type="results" id="sec013"><title><text><SENT sid="158" pm="."><plain>Results </plain></SENT>
</text></title><sec id="sec014"><title><text><SENT sid="159" pm="."><plain>HMGB1 as a biomarker for Plasmodium detection </plain></SENT>
</text></title><p><text><SENT sid="160" pm="."><plain>Recent advancements in the ‘omics field allow novel approaches to assess gene expression regulation at several stages, namely, gene transcription, mRNA translation and protein availability in the cell. </plain></SENT>
<SENT sid="161" pm="."><plain>Among these, translation regulation can be studied by RP, which provides unprecedented parameters, both qualitative and quantitative [37]. </plain></SENT>
<SENT sid="162" pm="."><plain>At any given cell growth state, RP can relatively estimate the ribosome load for each identified mRNA [37]. </plain></SENT>
<SENT sid="163" pm="."><plain>Recent applications of RP for P. falciparum identified more than 3,000 actively translated mRNAs at different stages of parasite life-cycle [9]. </plain></SENT>
<SENT sid="164" pm="."><plain>Actively translated mRNAs shall result in highly expressed proteins, an appealing feature to propose new potential biomarkers as parasite density can be estimated. </plain></SENT>
<SENT sid="165" pm="."><plain>Using the freely available RP databases, biomarker candidates were ranked according to their expression in the merozoite blood-stage, as being the stage with the most active protein synthesis apparatus (Fig 1A). </plain></SENT>
<SENT sid="166" pm="."><plain>Any gene whose expression was null during any blood stage was excluded since homogenous expression during all blood stages was desired as biomarkers that are present longer in the blood stages of P. falciparum can be advantageous increase the sensibility of infection detection. </plain></SENT>
<SENT sid="167" pm="."><plain>To assess the expression variability along blood-stages of P. falciparum the most expressed genes from RP datasets were validated by transcriptomic reports using PlasmoDB [18,19]. </plain></SENT>
<SENT sid="168" pm="."><plain>Candidates whose expression was not uniform during all blood stages were eliminated. </plain></SENT>
<SENT sid="169" pm="."><plain>Biomarker candidates that met both selection criteria, being abundant and showing similar expression patterns during all blood stages of the parasite, were pre-selected (Fig 1). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone.0211756.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0211756.g001</object-id><label>Fig 1</label><caption><title><text><SENT sid="170" pm="."><plain>HMG-box as a potential biomarker of Plasmodium falciparum. </plain></SENT>
</text></title><p><text><SENT sid="171" pm="."><plain>(A) Workflow for the identification of highly abundant proteins of Plasmodium falciparum as novel biomarker candidates. </plain></SENT>
<SENT sid="172" pm="."><plain>(B) Structure predictions by homology of HMG-box from P. falciparum and its human homolog using the Swiss-model suite [33]. </plain></SENT>
<SENT sid="173" pm="."><plain>(C) BLASTp suite of HMG-box Pf shows a high percentage of identity with other pathogenic Plasmodium species. </plain></SENT>
<SENT sid="174" pm="."><plain>(D) Clustal Omega (EMBL-EBI, UK) multiple sequence alignment for HMG-box Pf and HMG-box Hs. </plain></SENT>
<SENT sid="175" pm="."><plain>Both domains have 71 amino acids and share 39.4% of identity and 54.9% of similarity. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0211756.g001"/></fig></SecTag><p><text><SENT sid="176" pm="."><plain>Further bioinformatic analysis allowed to investigate structural features of the potential biomarkers. </plain></SENT>
<SENT sid="177" pm="."><plain>From the top five biomarker candidates, only fructose-bisphosphate aldolase (FBPA) had a known 3D structure (PDB 1A5C) [38]. </plain></SENT>
<SENT sid="178" pm="."><plain>However, the tertiary structure of HMGB1, eIF1, Tetraubiquitin, 14-3-3 protein was available from modeling based on proteins from other species that shared at least 40% of their amino acid sequence (Plasmo DB, [18]). </plain></SENT>
<SENT sid="179" pm="."><plain>From the five potential biomarkers of P. falciparum, HMGB1 showed up as being abundant, present along all blood-stages of the parasite and, folding into a stable tertiary structure (Fig 1B). </plain></SENT>
<SENT sid="180" pm="."><plain>Therefore, HMGB1 displays substantial premises for the development of molecular sensors for Plasmodium detection. </plain></SENT>
<SENT sid="181" pm="."><plain>The HMGB1 protein from Plasmodium spp. has a human homolog, and both contain a DNA binding domain, HMG-box (Fig 1B) [21]. </plain></SENT>
<SENT sid="182" pm="."><plain>Furthermore, the HMG-box domain is highly conserved among Plasmodium species that infect humans, such as P. vivax (88% identity), P. knowlesi (87% identity), P. malarie (85% identity), and P. ovale (81% identity) (Fig 1C). </plain></SENT>
<SENT sid="183" pm="."><plain>Of particular importance, HMG-box Pf shows limited identity (39.4%) with HMG-box Hs (Fig 1D). </plain></SENT>
<SENT sid="184" pm="."><plain>Altogether, abundance, availability during all infectious stages of the parasite, and low identity with the human counterpart make the HMG-box an appealing biomarker to develop new biosensors. </plain></SENT>
</text></p></sec><sec id="sec015"><title><text><SENT sid="185" pm="."><plain>Aptamers against HMG-box Pf </plain></SENT>
</text></title><p><text><SENT sid="186" pm="."><plain>In order to develop molecular sensors that can specifically recognize the HMG-box Pf, we used Systematic Evolution of Ligands by Exponential Enrichment (SELEX) combined with next-generation sequencing (NGS). </plain></SENT>
<SENT sid="187" pm="."><plain>SELEX allows to in vitro select single-stranded oligonucleotides that strongly bind a given molecule [13]. </plain></SENT>
<SENT sid="188" pm="."><plain>These oligonucleotides are known as aptamers [39] and were shown to have significant advantages over antibodies such as better thermal stability and synthesis consistency between production batches without compromising their binding affinities [11,40]. </plain></SENT>
<SENT sid="189" pm="."><plain>These characteristics are very appealing for further development of aptamers into rapid diagnostic tests to be deployed in rural areas in low-income countries, the most affected by Malaria. </plain></SENT>
<SENT sid="190" pm="."><plain>We performed fourteen SELEX cycles (Fig 2A) starting from a library of ssDNA containing 40 randomized nucleotides. </plain></SENT>
<SENT sid="191" pm="."><plain>In order to enhance the selection of tight binders, HMG-box Pf concentration, incubation time and strength of washes varied, increasing the selection stringency along the SELEX cycles (S2 Table). </plain></SENT>
<SENT sid="192" pm="."><plain>Whereas, to increase the specificity of the potential aptamers, negative selections using the human counterpart, HMG-box Hs, were introduced at cycles five, eight, ten, and fourteen. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone.0211756.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0211756.g002</object-id><label>Fig 2</label><caption><title><text><SENT sid="193" pm="."><plain>NGS allows the identification of aptamer motifs and their evolution during SELEX. </plain></SENT>
</text></title><p><text><SENT sid="194" pm="."><plain>(A) Workflow of the SELEX technique and variations applied in this work. </plain></SENT>
<SENT sid="195" pm="."><plain>The ssDNA library (N40) was incubated with the HMG-box proteins immobilized in magnetic beads. </plain></SENT>
<SENT sid="196" pm="."><plain>After incubation, a magnet is used to separate the ssDNA molecules that bound the proteins on the magnetic beads. </plain></SENT>
<SENT sid="197" pm="."><plain>To amplify the bound molecules a PCR using a modified reverse primer with the T7 promoter region is performed. </plain></SENT>
<SENT sid="198" pm="."><plain>After purification, in vitro transcription is carried out, followed by in vitro reverse transcription. </plain></SENT>
<SENT sid="199" pm="."><plain>Finally, an enriched ssDNA library is generated and used for a next cycle or for sequencing. </plain></SENT>
<SENT sid="200" pm="."><plain>(B) Progression of enrichment along steps of selection as evaluated by the DiVE technique [24]. </plain></SENT>
<SENT sid="201" pm="."><plain>The ratio between non-degraded DNA (enriched)/total DNA was calculated from image quantifications of the resulting agarose gel using the ImageJ software [41] (see material and methods). </plain></SENT>
<SENT sid="202" pm="."><plain>Rounds 4, 6, 8, 10 and 14 were chosen for NGS analysis. </plain></SENT>
<SENT sid="203" pm="."><plain>(C) Scheme depicting the workflow for sequence analysis. </plain></SENT>
<SENT sid="204" pm="."><plain>(D) MEME (The MEME Suite) was used to identify the most characteristic motifs in each sequenced SELEX cycle. </plain></SENT>
<SENT sid="205" pm="."><plain>Three motifs were the most represented in cycles 8 (motif 3), 10 (motif 2), and 14 (motif 1). </plain></SENT>
<SENT sid="206" pm="."><plain>Sequences from cycles 8 and 10 share a conserved region inside motifs 3 and 2, whereas this region is lost in motif 1. </plain></SENT>
<SENT sid="207" pm="."><plain>No representative motif was detected in cycle 4. </plain></SENT>
<SENT sid="208" pm="."><plain>(E) Dynamics of aptamer motifs along SELEX cycles. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0211756.g002"/></fig></SecTag><p><text><SENT sid="209" pm="."><plain>It is expected that the initial variability of the starting library decreases along the SELEX cycles, enriching a sub-population that contains the potential aptamers. </plain></SENT>
<SENT sid="210" pm="."><plain>To assess the enrichment of aptamers over the high variability of the starting library, we used the DiVE assay [24] and bioinformatic analysis of sequencing data (see below). </plain></SENT>
<SENT sid="211" pm="."><plain>DiVE uses the S1 endonuclease to differentiate between homoduplex and heteroduplex dsDNA by cleaving short single-stranded ends, nicks, and heteroduplex loops. </plain></SENT>
<SENT sid="212" pm="."><plain>An enriched pool would have more dsDNA homoduplex compared with a non-enriched pool. </plain></SENT>
<SENT sid="213" pm="."><plain>Thus, the homoduplex would not be cleaved and could be visualized in an agarose gel. </plain></SENT>
<SENT sid="214" pm="."><plain>The DiVE assay allowed to confirm enrichment at cycles eight, ten, and fourteen with a loss of homogeneity from cycle eleven to thirteen (Fig 2B and S1 Fig). </plain></SENT>
<SENT sid="215" pm="."><plain>The dsDNA obtained from cycles four, six, eight, ten, and fourteen were used for NGS using the Illumina system. </plain></SENT>
</text></p><p><text><SENT sid="216" pm="."><plain>Raw sequences (typically over 80,000 reads for each SELEX cycle) obtained from sequencing were processed using the FASTAptamer toolkit (Fig 2C) [25]. </plain></SENT>
<SENT sid="217" pm="."><plain>Briefly, a FASTQ file was processed using the algorithm FASTAptamer Count that ranks DNA sequences based on their abundance for each SELEX cycle (Refer to S1 Data for raw ranked sequences). </plain></SENT>
<SENT sid="218" pm="."><plain>Best ranked sequences in cycle 14 varied between 14,995 RPM (Reads per Million, a normalized index for frequency) and 27,6943 RPM. </plain></SENT>
<SENT sid="219" pm="."><plain>In cycle ten, the most abundant sequences ranged between 5,933 RPM and 103,658 RPM. </plain></SENT>
<SENT sid="220" pm="."><plain>Final rounds of selection provided fewer sequences with higher frequency, while earlier selection cycles did not show sequences over 190 RPM of representation (For raw data, refer to S2 Data). </plain></SENT>
<SENT sid="221" pm="."><plain>An important indicator of aptamer selection can be surmised from the enrichment of each sequence along the selection procedure. </plain></SENT>
<SENT sid="222" pm="."><plain>This can be estimated from the ratio of sequence frequencies belonging to successive SELEX cycles. </plain></SENT>
<SENT sid="223" pm="."><plain>Thus, we used the FASTAptamer Enrich algorithm to calculate the enrichment of all aptamer sequences over two SELEX cycles, i.e., fourteen over ten or ten over eight. </plain></SENT>
<SENT sid="224" pm="."><plain>Most enriched sequences showed a frequency ratio ranging from 82 to 566 in cycles fourteen over ten. </plain></SENT>
<SENT sid="225" pm="."><plain>The enrichment ratio for cycles ten over eight showed increased enrichment ranging between 24.1 and 16.5 (See S3 Data for all sequences). </plain></SENT>
<SENT sid="226" pm="."><plain>Combining the results from both, ranking and enrichment, nine potential aptamers were identified (Table 1). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone.0211756.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0211756.t001</object-id><label>Table 1</label><caption><title><text><SENT sid="227" pm="."><plain>Top-ranked and enriched sequences as evaluated by NGS. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone.0211756.t001g" xlink:href="pone.0211756.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1"><text><SENT sid="228" pm="."><plain>Name </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="229" pm="."><plain>Sequencea </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="230" pm="."><plain>ΔG(Kcal/mol)b </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="231" pm="."><plain>Rankingc </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="232" pm="."><plain>Enrichmentc </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="233" pm="."><plain>Kd(nM)d </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="234" pm="."><plain>Δ MST(a.u.)e </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="235" pm="."><plain>PfR1 </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="236" pm="."><plain>GAGAAGGACTGCTTAGGCTTGCGATGTGAAATCTGTAATC </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="237" pm="."><plain>-3.92 </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="238" pm="."><plain>1(14) </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="239" pm="."><plain>4.13(14/10) </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="240" pm="."><plain>175 ± 54 </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="241" pm="."><plain>7.6 ± 0.6 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="242" pm="."><plain>PfR2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="243" pm="."><plain>AGATGCAAAGGACTGCTCAGGCTTGCGATGGCAGCTTCAT </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="244" pm="."><plain>-5.72 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="245" pm="."><plain>2(14) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="246" pm="."><plain>32.05(14/10) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="247" pm="."><plain>778 ± 1020 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="248" pm="."><plain>4 ± 2 </plain></SENT>
</text></td></tr><tr><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="249" pm="."><plain>PfR3 </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="250" pm="."><plain>CACTAGGTCTGCTTAGGATTGCGTAAGTGAAAGTCATTTA </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="251" pm="."><plain>-6.43 </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="252" pm="."><plain>3(14) </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="253" pm="."><plain>566.11(14/10) </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="254" pm="."><plain>1930 ± 560 </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="255" pm="."><plain>18 ± 3 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="256" pm="."><plain>PfR4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="257" pm="."><plain>ACCGACTACGTCAACCTGGGTCTGCTCGGGATTGCGGATG </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="258" pm="."><plain>-6.92 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="259" pm="."><plain>1(10) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="260" pm="."><plain>8.68(10/8) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="261" pm="."><plain>41 ± 11 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="262" pm="."><plain>8.6 ± 0.6 </plain></SENT>
</text></td></tr><tr><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="263" pm="."><plain>PfR5 </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="264" pm="."><plain>AGCCGTGGATTGCAAAGGGCTGCTGTGGCTTAGTTGAATG </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="265" pm="."><plain>-5.33 </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="266" pm="."><plain>3(10) </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="267" pm="."><plain>18.38(10/8) </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="268" pm="."><plain>560 ± 120 </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="269" pm="."><plain>8.5 ± 0.6 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="270" pm="."><plain>PfR6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="271" pm="."><plain>CGCGTGGGTTTGGCTCCGGGCCTGGCGGATGCACGTATAG </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="272" pm="."><plain>-6.11 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="273" pm="."><plain>5(10) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="274" pm="."><plain>2.18(10/8) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="275" pm="."><plain>65 ± 15 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="276" pm="."><plain>7 ± 0.6 </plain></SENT>
</text></td></tr><tr><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="277" pm="."><plain>PfE1 </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="278" pm="."><plain>GCCGACTACGTCAACCTGGGTCTGCTCGGGATTGCGGATG </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="279" pm="."><plain>-7.53 </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="280" pm="."><plain>4(10) </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="281" pm="."><plain>24.10(10/8) </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="282" pm="."><plain>81 ± 20 </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="283" pm="."><plain>8.8 ± 0.5 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="284" pm="."><plain>PfE2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="285" pm="."><plain>ACCGACTACGTCAACTTGGGTCTGCTCGGGATTGCGGATG </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="286" pm="."><plain>-6.92 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="287" pm="."><plain>14(10) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="288" pm="."><plain>18.58(10/8) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="289" pm="."><plain>55 ± 20 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="290" pm="."><plain>7.8 ± 0.7 </plain></SENT>
</text></td></tr><tr><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="291" pm="."><plain>PfE3 </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="292" pm="."><plain>AGTTTACACCAAGGACTGCTTAGGATTGCGTTAGGGTATT </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="293" pm="."><plain>-2.93 </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="294" pm="."><plain>10(14) </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="295" pm="."><plain>301.81(14/10) </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="296" pm="."><plain>815 ± 158 </plain></SENT>
</text></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><text><SENT sid="297" pm="."><plain>17 ± 0.6 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p><text><SENT sid="298" pm="."><plain>a Top-ranked and enriched sequences obtained by bioinformatic analysis. </plain></SENT>
<SENT sid="299" pm="."><plain>Here, we show the N40 central region of the aptamers, excluding the flanking 5’ (TAGGGAAGAGAAGGACATATGAT) and 3’ (TTGACTAGTACATGACCACTTGA) regions. </plain></SENT>
</text></p></fn><fn id="t001fn002"><p><text><SENT sid="300" pm="."><plain>b Gibbs free energy was calculated considering the flanking regions using the Mfold web server (See S3 Fig for secondary structure predictions). </plain></SENT>
<SENT sid="301" pm="."><plain>Ranking and enrichment values were taken from the FASTAptamer toolkit [25]. </plain></SENT>
</text></p></fn><fn id="t001fn003"><p><text><SENT sid="302" pm="."><plain>c The cycle in which the aptamer was obtained, whether by Ranking or Enrichment, is shown in parenthesis. </plain></SENT>
</text></p></fn><fn id="t001fn004"><p><text><SENT sid="303" pm="."><plain>d Aptamer Kd values were obtained by Microscale Thermophoresis (Fig 3A and 3B). </plain></SENT>
</text></p></fn><fn id="t001fn005"><p><text><SENT sid="304" pm="."><plain>e Thermophoretic amplitude changes as an indicator of the extent of binding. </plain></SENT>
<SENT sid="305" pm="."><plain>Mean values and standard error were calculated from three independent measurements. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="306" pm="."><plain>Additionally, sequences from the sequential selection process were also used to select for families of aptamers sharing a common and conserved sequence with few substitutions within the sequence. </plain></SENT>
<SENT sid="307" pm="."><plain>The variability within each family can arise either from the original library or by synthesis errors of the Taq polymerase, T7 RNA polymerase, or retro transcriptase that were used to regenerate the pool of ssDNA. </plain></SENT>
<SENT sid="308" pm="."><plain>To further analyze how families are enriched along the SELEX cycles of selection, we used the FASTAptamer Cluster algorithm [25] together with MEME Suite Motif Analysis and the Clustal Omega [22,26]. </plain></SENT>
<SENT sid="309" pm="."><plain>Representative motifs in cycles eight, ten, and fourteen were identified (Fig 2D). </plain></SENT>
<SENT sid="310" pm="."><plain>Motif 3 was the most abundant in cycle eight with about 40% of share. </plain></SENT>
<SENT sid="311" pm="."><plain>However, motif 3 diminished in cycles ten and fourteen, concomitantly with an increase of share for motif 2. </plain></SENT>
<SENT sid="312" pm="."><plain>A relative abundance of 70% for this family was followed by a reduction to less than 20% in cycle fourteen. </plain></SENT>
<SENT sid="313" pm="."><plain>On the other hand, motif 1, with low representation in cycles eight and ten, appeared highly abundant in cycle fourteen, with 80% of share (Fig 2E). </plain></SENT>
<SENT sid="314" pm="."><plain>Motif 1 was represented by sequences PfR1, PfR2, PfR3, and PfE3. </plain></SENT>
<SENT sid="315" pm="."><plain>Whereas motif 2 was represented by sequences PfR4, PfR5, PfR6, PfE1, and PfE2. </plain></SENT>
<SENT sid="316" pm="."><plain>PfR4 and PfE1 shared motif 2 and 3 within their sequences (Table 1). </plain></SENT>
<SENT sid="317" pm="."><plain>Overall, the bioinformatic flow used here allowed to identify nine potential aptamers for the HMG-box Pf, with three representing families of aptamers that vary their relative abundances along the SELEX process (Table 1, Fig 2E). </plain></SENT>
</text></p></sec><sec id="sec016"><title><text><SENT sid="318" pm="."><plain>Interaction parameters between aptamers and HMG-box Pf </plain></SENT>
</text></title><p><text><SENT sid="319" pm="."><plain>Nine aptamers, among the best, ranked or enriched, and belonging to the three most represented motifs were chemically synthesized and tested for binding to the HMG-box Pf using Microscale Thermophoresis (MST). </plain></SENT>
<SENT sid="320" pm="."><plain>MST allows the analysis of molecular interactions by measuring drifts of fluorescent reporters that are induced by small temperature changes, named thermophoresis [42,43]. </plain></SENT>
<SENT sid="321" pm="."><plain>The degree of thermophoresis change depends on the bound and unbound state of the fluorescent reporter with the ligand. </plain></SENT>
<SENT sid="322" pm="."><plain>Therefore, the thermophoresis changes as a function of ligand concentration allow calculating dissociation constants (Kd) [42]. </plain></SENT>
<SENT sid="323" pm="."><plain>Several MST applications for aptamer research have been reported (see [44] for detailed methods). </plain></SENT>
<SENT sid="324" pm="."><plain>Here, we label the aptamer with a fluorescent probe (probeFAM) and use it at a constant concentration and increased the concentrations of HMG-box Pf, ranging from 0.1 nM to 2 μM. </plain></SENT>
<SENT sid="325" pm="."><plain>The measured affinities ranged from 50 nM to 2 μM, with aptamers PfR1, PfR4, PfR6, PfE1, and PfE2 being in the low nanomolar range and PfR2, PfR5, and PfE3 in the micromolar range of dissociation constants (Table 1) (Fig 3A and 3B). </plain></SENT>
<SENT sid="326" pm="."><plain>PfR6 was representative of the group showing high affinities, while aptamer PfE3 showed the greatest MST amplitude at a lower affinity. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone.0211756.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0211756.g003</object-id><label>Fig 3</label><caption><title><text><SENT sid="327" pm="."><plain>Aptamers efficiently bind the HMG-box from P. falciparum. </plain></SENT>
</text></title><p><text><SENT sid="328" pm="."><plain>MST analysis of the interaction between aptamers and HMG-box. </plain></SENT>
<SENT sid="329" pm="."><plain>(A) Thermophoresis changes of best ranked aptamers as a function of HMG-box Pf concentration. </plain></SENT>
<SENT sid="330" pm="."><plain>(B) Thermophoresis changes of the most enriched aptamers as a function of HMG-box Pf concentration. </plain></SENT>
<SENT sid="331" pm="."><plain>Specificity assessment for PfR6 (C) and PfE3 (D). </plain></SENT>
<SENT sid="332" pm="."><plain>The binding of each aptamer to HMG-box Pf (open circles) was compared to the human homolog (open squares) or in the absence of the aptamer (open triangles). </plain></SENT>
<SENT sid="333" pm="."><plain>All reactions were measured in triplicates. </plain></SENT>
<SENT sid="334" pm="."><plain>Error bars indicate standard deviations. </plain></SENT>
<SENT sid="335" pm="."><plain>Continuous lines show the non-linear regression using a quadratic equation, allowing to estimate a Kd values (Table 1). </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0211756.g003"/></fig></SecTag><p><text><SENT sid="336" pm="."><plain>Another parameter to consider for optimal aptamers lays on specificity determinants. </plain></SENT>
<SENT sid="337" pm="."><plain>Thus, we probed PfR6 and PfE3 binding to HMG-box Hs by MST. </plain></SENT>
<SENT sid="338" pm="."><plain>The extent of binding PfR6 to the human homolog of HMG-box was lower when compared to the Plasmodium counterpart (Fig 3C). </plain></SENT>
<SENT sid="339" pm="."><plain>However, the PfE3 aptamer showed residual capacity to interact with HGM-box Hs, however with a 10-fold reduced affinity (Fig 3D). </plain></SENT>
<SENT sid="340" pm="."><plain>In brief, PfR6 shows better specificity than PfE3 as less binding to the Hs HGM-box1 was observed (Fig 3C and 3D) while aptamer PfE3 showed the greatest MST amplitude but a lower affinity (Fig 3A and 3B). </plain></SENT>
</text></p><p><text><SENT sid="341" pm="."><plain>In order to further analyze the binding determinants of the PfR6 interaction with HMG-box Pf, we studied the kinetics of the reaction by the Stopped-flow (SF) technique. </plain></SENT>
<SENT sid="342" pm="."><plain>SF allows monitoring changes of fluorescence or absorbance in time and upon rapid mixing of two reactants. </plain></SENT>
<SENT sid="343" pm="."><plain>Here we used Föster Resonance Energy Transfer (FRET) between HMG-box (Pf or Hs) modified with the acceptor dye Atto540Q (from herein, HMG-box540Q Pf or Hs) and the PfR6 aptamer pre-annealed with a small complementary probe labeled with Fluorescein (PfR6FAM) (see material and methods). </plain></SENT>
<SENT sid="344" pm="."><plain>The interaction between the fluorescent aptamer and the quenching HMG-box resulted in a fluorescence decrease in time, due to the quenching effect induced by the vicinity of the non-emitting acceptor Atto540Q to the fluorescein reporter in the aptamer. </plain></SENT>
<SENT sid="345" pm="."><plain>To assess the specificity of the signal, first, we mixed HMG-box540Q Pf with the fluorescent probe only (in the absence of aptamer PfR6) and resulted in a negligible fluorescence change in time, indicating low or no interaction between the reactants (Fig 4A). </plain></SENT>
<SENT sid="346" pm="."><plain>Consistently, the mixing of PfR6FAM with the unlabeled HMG-box Pf did not result in any fluorescence change in time. </plain></SENT>
<SENT sid="347" pm="."><plain>Mixing HMG-box540Q Pf with PfR6FAM resulted in a decrease of fluorescence over time, consistent with a rapid binding of PfR6FAM with HMG-box540Q Pf. </plain></SENT>
<SENT sid="348" pm="."><plain>Nonlinear analysis with an exponential function allowed estimating the apparent average rate of the interaction, kAV = 0.58 ± 0.01 s–1. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone.0211756.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0211756.g004</object-id><label>Fig 4</label><caption><title><text><SENT sid="349" pm="."><plain>Kinetics of PfR6 interaction with HMG-box. </plain></SENT>
</text></title><p><text><SENT sid="350" pm="."><plain>HMG-box540Q and PfR6FAM were used to monitor the interaction between the aptamer and the protein in real-time using a stopped-flow apparatus (Applied Photophysics, UK). </plain></SENT>
<SENT sid="351" pm="."><plain>(A) FRET between HMG-box540Q and PfR6FAM. </plain></SENT>
<SENT sid="352" pm="."><plain>Mixing the labeled protein with the probe-bound aptamer (green) resulted in a decrease of fluorescence over time, indicating that the binding of both components results in the quenching of fluorescein due to its vicinity with the quencher in the protein. </plain></SENT>
<SENT sid="353" pm="."><plain>FRET assessment controls lacking the aptamer or the quencher Atto-540 in the HMG-box are shown in orange and purple traces respectively. </plain></SENT>
<SENT sid="354" pm="."><plain>(B) HMG-box 540Q Pf (green) or HMG-box 540Q Hs (blue) comparison during the binding with PfR6FAM at pH 5.5. </plain></SENT>
<SENT sid="355" pm="."><plain>7–10 replicates for each reaction were measured and averaged. </plain></SENT>
<SENT sid="356" pm="."><plain>Continuous lines show the fitting with exponential functions. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0211756.g004"/></fig></SecTag><p><text><SENT sid="357" pm="."><plain>Similar experiments using the human counterpart of the biomarker, HMG-box540Q Hs, showed variable degrees of binding as a function of pH. </plain></SENT>
<SENT sid="358" pm="."><plain>At pH = 5.5, PfR6 did not show any binding to HMG-box540Q Hs while the binding to the plasmodium counterpart was maintained (Fig 4B). </plain></SENT>
<SENT sid="359" pm="."><plain>Thus, PfR6 appears to bind specifically to HMG-box540Q Pf at the given conditions. </plain></SENT>
<SENT sid="360" pm="."><plain>However, the specificity of the binding was found to be perturbed by increasing the pH (S2 Fig). </plain></SENT>
<SENT sid="361" pm="."><plain>Nonlinear regression showed an average rate constant kAV = 0.18 ± 0.02 s–1 for PfR6 interaction with HMG-box540Q Pf. </plain></SENT>
<SENT sid="362" pm="."><plain>This rate increased with pH, reaching kAV = 1.12 s–1. </plain></SENT>
<SENT sid="363" pm="."><plain>Ion concentrations and pH have been shown to influence the tertiary structure of aptamers, therefore affecting their binding properties [45]. </plain></SENT>
<SENT sid="364" pm="."><plain>Altogether, our results indicate that PfR6 interacts efficient- and rapidly with the HMG-box Pf domain and provide experimental conditions where the specificity of the interaction is greatly enhanced. </plain></SENT>
</text></p></sec><sec id="sec017"><title><text><SENT sid="365" pm="."><plain>Structural model of the PfR6– HMG-box Pf complex </plain></SENT>
</text></title><p><text><SENT sid="366" pm="."><plain>In order to evaluate the theoretical molecular interactions between aptamers and HMG-box Pf, 3D models of the aptamers were generated followed by a molecular docking approximation. </plain></SENT>
<SENT sid="367" pm="."><plain>Secondary structures of the aptamers were predicted by MFold (S3 Fig) [27]. </plain></SENT>
<SENT sid="368" pm="."><plain>Then, the RNAComposer tool was used to generate 3D RNA models of the aptamers. </plain></SENT>
<SENT sid="369" pm="."><plain>The resulting models were converted to DNA structures with VMD and then stabilized through 10,000 iterations of energy minimization as described by Jeddi I. and Saiz L. [28]. </plain></SENT>
<SENT sid="371" pm="."><plain>2D and 3D predictions indicated that all nine aptamers showed unstructured regions at the 5’ end. </plain></SENT>
<SENT sid="372" pm="."><plain>The length of the unstructured regions varied between 10 and 26 bases (S3 and S5 Figs). </plain></SENT>
<SENT sid="373" pm="."><plain>On the other hand, the 3’ end contained highly structured domains that included the 3’ flanking regions of the aptamer library (S5 Fig). </plain></SENT>
<SENT sid="374" pm="."><plain>PfR6 showed 21 (out of 86) unstructured nucleotides at the 5' end. </plain></SENT>
<SENT sid="375" pm="."><plain>The structured 3' region showed three segments with short double-stranded helixes and several helix-to-helix interactions (Fig 5A). </plain></SENT>
<SENT sid="376" pm="."><plain>Thus, PfR6 appears to fold into significantly structured regions, at the same time, provides a long unstructured segment that could be exploited to further develop diagnostic tests. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone.0211756.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0211756.g005</object-id><label>Fig 5</label><caption><title><text><SENT sid="377" pm="."><plain>Structural modeling of aptamers and the PfR6–HMG-box Pf complex. </plain></SENT>
</text></title><p><text><SENT sid="378" pm="."><plain>(A) Tertiary structure prediction of the PfR6 aptamer. </plain></SENT>
<SENT sid="379" pm="."><plain>(B) Alternative models for the PfR6–HMG-box Pf complex as evaluated by ZDOCK [34]. </plain></SENT>
<SENT sid="380" pm="."><plain>The degree of opacity is proportional to the ZDOCK Score (10% opacity corresponding to a score of 1350, maximum opacity corresponds to a score of 1850) (S6 Fig). </plain></SENT>
<SENT sid="381" pm="."><plain>(C) as B for the PfR6–HMG-box Hs. </plain></SENT>
<SENT sid="382" pm="."><plain>The PfR6 aptamer is depicted in sky blue, the HMG-box Pf in pale green, and HMG-box Hs in pink. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0211756.g005"/></fig></SecTag><p><text><SENT sid="383" pm="."><plain>Modeling of the PfR6–HMG-box Pf complex was performed using the predicted tertiary structures of the aptamer and the protein (see above) using the ZDOCK tool [34]. </plain></SENT>
<SENT sid="384" pm="."><plain>We generated 2,000 complexes for each aptamer and evaluated their respective docking score based on rigid bodies interactions (S4 Data, S6 Fig). </plain></SENT>
<SENT sid="385" pm="."><plain>The average value of the docking scores did not indicate substantial differences between the aptamers. </plain></SENT>
<SENT sid="386" pm="."><plain>However, the highest score varied for each aptamer, ranging from 1500 to 1850, with PfE3 and PfR6 among the highest ones (S6 Fig). </plain></SENT>
<SENT sid="387" pm="."><plain>Thus, in silico docking results appear to be consistent with the biochemical data as measured by MST (Fig 3, Table 1). </plain></SENT>
<SENT sid="388" pm="."><plain>A comparison among the best ten PfR6–HMG-box Pf complexes, as evaluated by the ZDOCK score, indicates that in eight out ten models HMG-box Pf interacts with the structured region of PfR6 (Fig 5B). </plain></SENT>
<SENT sid="389" pm="."><plain>As a comparison, the PfR6–HMG-box Hs complex (human counterpart) showed much lower ZDOCK scores; however, the first ten models show an interaction of the protein with the structured region of the aptamer (Fig 5C). </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="DISCUSS"><sec sec-type="conclusions" id="sec018"><title><text><SENT sid="390" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="391" pm="."><plain>The identification of potential biomarkers is a complex process where many factors must be considered. </plain></SENT>
<SENT sid="392" pm="."><plain>In the case of Plasmodium species, an ideal biomarker should establish the presence or absence of infection, determine the species involved, be detectable at low concentrations, and be proportional to parasite density [46]. </plain></SENT>
<SENT sid="393" pm="."><plain>To account for these characteristics, the successful entrepreneurship requires several experimental stages, from basic research towards final clinical validations. </plain></SENT>
<SENT sid="394" pm="."><plain>Initial steps for biomarker selection can be pursued using bioinformatic strategies, with large databases of the -omics providing valid alternatives [47,48]. </plain></SENT>
<SENT sid="395" pm="."><plain>Genome-wide translation dynamics studies as revealed by RP, and in contrast to transcriptomic approaches, offer a precise approximation for the P. falciparum proteome [9]. </plain></SENT>
<SENT sid="396" pm="."><plain>Secondary analysis of RP datasets allowed selecting HGMB1 as a highly expressed protein during all the blood stages of P. falciparum (Fig 1, S1 Table). </plain></SENT>
<SENT sid="397" pm="."><plain>Structural stability, conservation among Plasmodium spp., and diversity to human homologs provided additional properties to cope for an ideal biomarker (Fig 1). </plain></SENT>
<SENT sid="398" pm="."><plain>Conserved regions of proteins from Plasmodium could be exploited to generate biosensors for the genus. </plain></SENT>
<SENT sid="399" pm="."><plain>Conversely, non-conserved regions allow generating species-specific biosensors [49]. </plain></SENT>
<SENT sid="400" pm="."><plain>Alternative approaches for the selection of biomarkers for malaria have been described [50], leading to different candidates for biomarkers, however, considering biomarker abundance shall increase the detection likelihood of the corresponding biosensors. </plain></SENT>
<SENT sid="401" pm="."><plain>As a comparison, during merozoite blood-stage, HGMB1 showed 88.45 folds more expression than the commonly used PfLDH biomarker, while HRP-2 expression is null. </plain></SENT>
</text></p><p><text><SENT sid="402" pm="."><plain>HMGB1 is a highly conserved non-histone protein among eukaryotes that binds the minor groove of DNA and enhances the activity of transcription factors [51]. </plain></SENT>
<SENT sid="403" pm="."><plain>HMGB1 of H. sapiens can be exported to the extracellular medium and can fulfill a role as an alarmin by being involved in infectious and non-infectious inflammatory conditions [52]. In vivo assays showed that HMGB1 Pf to be an inducing factor for potent pro-inflammatory processes, leading to the induction of TNF-α and Nitric Oxide Synthase [51]. </plain></SENT>
<SENT sid="404" pm="."><plain>Both, transcriptional enhancer and extracellular activities, add additional features to HMGB1 as a biomarker. </plain></SENT>
<SENT sid="405" pm="."><plain>One can expect that Plasmodium spp. exploit the natural regulatory network of the human HMGB1 by exporting HMGB1 Pf, although, to our knowledge, experimental evidence is still lacking. </plain></SENT>
<SENT sid="406" pm="."><plain>Deletion of the HMGB2 homolog from Plasmodium resulted in attenuated pathogenicity in mouse models [53], indicating an involvement on severe inflammatory responses. </plain></SENT>
<SENT sid="407" pm="."><plain>HMGB1 and HMGB2 are differentially expressed in the Plasmodium cycle, with HMGB1 Pf preferentially expressed during erythrocytic stages and HMGB2 Pf during gametocytes [54]. </plain></SENT>
<SENT sid="408" pm="."><plain>Although HMGB1 and HMGB2 could to be implicated in the inflammatory response of the host, they are more likely involved in proliferation (HMGB1 Pf) and differentiation (HMGB2 Pf) of P. falciparum[55]; making the HMGB family a candidate for directed inhibitory drugs. </plain></SENT>
<SENT sid="409" pm="."><plain>Backing up this notion, aptamers targeting a wide spectrum of diseases are currently being evaluated in clinical trials (reviewed in [56]). </plain></SENT>
<SENT sid="410" pm="."><plain>Here, we showed that PfR6 tightly bind the conserved domain HMG-box displaying affinities that are comparable to antibodies used as biological drugs. </plain></SENT>
<SENT sid="411" pm="."><plain>Besides their potential for pharmacological administration, PfR6 may further be modified as a biosensor of HMGB1 from P. falciparum. </plain></SENT>
</text></p><p><text><SENT sid="412" pm="."><plain>Aptamers for the detection of infectious diseases are of remarkably flexibility for the development of diagnostic assays. </plain></SENT>
<SENT sid="413" pm="."><plain>Such versatility arises from uncountable chemical modifications that are commercially available. </plain></SENT>
<SENT sid="414" pm="."><plain>Aptamer-tethered enzymes have been shown of great sensibility and to differentiate P. falciparum from P. vivax in blood samples [57]. </plain></SENT>
<SENT sid="415" pm="."><plain>Additionally, the development of aptamers using species specific epitopes allowed to isolate an aptamer that could accurately discriminate between the above species [49]. </plain></SENT>
<SENT sid="416" pm="."><plain>Aptamers against PfLDH were used in impedance spectroscopy setups allowing to propose electrochemical sensors that recognize the biomarker at a wide range of conditions [58]. </plain></SENT>
<SENT sid="417" pm="."><plain>Measurements of intramolecular FRET between aptamer linked dyes allowed the development of aptamer beacons [59]. </plain></SENT>
<SENT sid="418" pm="."><plain>In this work we show that fluorescently modified aptamers PfR6 and PfE3 allowed to monitor the binding to HGM-box Pf using two different techniques, providing substantial premises to develop aptamer beacons. </plain></SENT>
<SENT sid="419" pm="."><plain>Indeed, stopped-flow assays resulted in large FRET changes that, in principle, are compatible with further developing of detection assays. </plain></SENT>
<SENT sid="420" pm="."><plain>Alternatively, aptamers can be enzyme-linked and used for rapid colorimetric detection of Malaria as recently shown for aptamers against PfLDH, offering a quantitative test that is both, sensitive and specific [60,61]. </plain></SENT>
<SENT sid="421" pm="."><plain>PfR6, developed here, interacts with HMG-box Pf rapidly, taking place in less than a minute. </plain></SENT>
<SENT sid="422" pm="."><plain>Both, high affinity and rapid binding, can allow the development RDTs with low detection times, and could be integrated into microfluidic devices as shown for aptamers against PfLDH. </plain></SENT>
</text></p><p><text><SENT sid="423" pm="."><plain>The chemical flexibility of aptamers can furthermore be exploited for binding optimization and stability in complex samples such as blood, plasma, saliva, etc. </plain></SENT>
<SENT sid="424" pm="."><plain>Indeed, the introduction of unnatural modifications can result in increased diversity, higher affinity as well as providing inhibitory capabilities [62]. </plain></SENT>
<SENT sid="425" pm="."><plain>The introduction of a single phosphorodithioate substitution resulted in a 1000-fold increase of affinity for an RNA aptamer against thrombin, leading to picomolar dissociation constants [63]. </plain></SENT>
<SENT sid="426" pm="."><plain>PfR6 showed binding affinities in the nanomolar range which could be further increased by targeted substitutions. </plain></SENT>
</text></p><p><text><SENT sid="427" pm="."><plain>RDTs are the best alternative for rapid screening and detection of malaria in emerging countries, and the present research allows to cope with two current limitations. </plain></SENT>
<SENT sid="428" pm="."><plain>First, HMG-box Pf, is proposed as an alternative biomarker to the mostly available HRP and LDH. </plain></SENT>
<SENT sid="429" pm="."><plain>Second, the development of aptamers and their fluorescent derivatives as potentially new biosensors of HMG-box Pf. </plain></SENT>
<SENT sid="430" pm="."><plain>The latter can be further investigated in order to develop alternative detection methods, i.e. enzyme-tethered, surface immobilized or molecular beacons. </plain></SENT>
</text></p></sec></SecTag><SecTag type="SUPPL"><sec sec-type="supplementary-material" id="sec019"><title><text><SENT sid="431" pm="."><plain>Supporting information </plain></SENT>
</text></title><supplementary-material content-type="local-data" id="pone.0211756.s001"><label>S1 Data</label><caption><title><text><SENT sid="432" pm="."><plain>Aptamer frequency analysis by the Fastaptamer count algorithm. </plain></SENT>
</text></title><p><text><SENT sid="433" pm="."><plain>(XLSX) </plain></SENT>
</text></p></caption><media xlink:href="pone.0211756.s001.xlsx"><caption><p><text><SENT sid="434" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0211756.s002"><label>S2 Data</label><caption><title><text><SENT sid="435" pm="."><plain>Aptamer ranking for all sequenced SELEX round. </plain></SENT>
</text></title><p><text><SENT sid="436" pm="."><plain>(XLSX) </plain></SENT>
</text></p></caption><media xlink:href="pone.0211756.s002.xlsx"><caption><p><text><SENT sid="437" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0211756.s003"><label>S3 Data</label><caption><title><text><SENT sid="438" pm="."><plain>Aptamer enrichment analysis by the Fastaptamer Enrich algorithm. </plain></SENT>
</text></title><p><text><SENT sid="439" pm="."><plain>(XLSX) </plain></SENT>
</text></p></caption><media xlink:href="pone.0211756.s003.xlsx"><caption><p><text><SENT sid="440" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0211756.s004"><label>S4 Data</label><caption><title><text><SENT sid="441" pm="."><plain>ZDOCK scores for 2,000 iterations corresponding to the nine aptamers. </plain></SENT>
</text></title><p><text><SENT sid="442" pm="."><plain>(XLSX) </plain></SENT>
</text></p></caption><media xlink:href="pone.0211756.s004.xlsx"><caption><p><text><SENT sid="443" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0211756.s005"><label>S1 Fig</label><caption><title><text><SENT sid="444" pm="."><plain>Aptamer enrichment analysis by the DiVE assay. </plain></SENT>
</text></title><p><text><SENT sid="445" pm="."><plain>See materials and methods for further details. </plain></SENT>
</text></p><p><text><SENT sid="446" pm="."><plain>(PDF) </plain></SENT>
</text></p></caption><media xlink:href="pone.0211756.s005.pdf"><caption><p><text><SENT sid="447" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0211756.s006"><label>S2 Fig</label><caption><title><text><SENT sid="448" pm="."><plain>Kinetics of PfR6 interaction with HMG-box Pf and Hs at pH 7.5. </plain></SENT>
</text></title><p><text><SENT sid="449" pm="."><plain>HMG-box540Q and PfR6FAM were used to monitor the interaction between the aptamer and the protein in real-time using a stopped-flow apparatus (Applied Photophysics, UK). </plain></SENT>
<SENT sid="450" pm="."><plain>HMG-box Pf Atto540Q labeled (green) or HMG-box Hs Atto540Q labeled (blue) comparison during the binding with PfR6FAM. </plain></SENT>
<SENT sid="451" pm="."><plain>Seven to ten replicates for each reaction were measured and averaged. </plain></SENT>
<SENT sid="452" pm="."><plain>Continuous lines show the fitting with exponential functions. </plain></SENT>
</text></p><p><text><SENT sid="453" pm="."><plain>(PDF) </plain></SENT>
</text></p></caption><media xlink:href="pone.0211756.s006.pdf"><caption><p><text><SENT sid="454" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0211756.s007"><label>S3 Fig</label><caption><title><text><SENT sid="455" pm="."><plain>Secondary structures of top-ranked and enriched aptamers. </plain></SENT>
</text></title><p><text><SENT sid="456" pm="."><plain>Here, we show the N40 variable region of the aptamers, including the flanking 5’ (TAGGGAAGAGAAGGACATATGAT) and 3’ (TTGACTAGTACATGACCACTTGA) regions. </plain></SENT>
<SENT sid="457" pm="."><plain>Secondary structures were predicted considering the flanking regions, at 25oC, 100 mM Na+, and 3 mM Mg2+, using the Mfold web server. </plain></SENT>
</text></p><p><text><SENT sid="458" pm="."><plain>(PDF) </plain></SENT>
</text></p></caption><media xlink:href="pone.0211756.s007.pdf"><caption><p><text><SENT sid="459" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0211756.s008"><label>S4 Fig</label><caption><title><text><SENT sid="460" pm="."><plain>MST analysis of the aptamer-HGM-box complex formation. </plain></SENT>
</text></title><p><text><SENT sid="461" pm="."><plain>(A) Thermophoresis changes of PfR6 as a function of HMG-box Pf concentration. </plain></SENT>
<SENT sid="462" pm="."><plain>Continuous line shows the non-linear regression using a quadratic equation, allowing to estimate a Kd of 64 ± 20 nM and a thermophoretic amplitude of 7 AU. </plain></SENT>
<SENT sid="463" pm="."><plain>(B) As A for the PfE3 aptamer. </plain></SENT>
<SENT sid="464" pm="."><plain>The estimated Kd was 740 ± 120 nM and an amplitude of 16 AU. </plain></SENT>
<SENT sid="465" pm="."><plain>Specificity assessment for PfR6. </plain></SENT>
</text></p><p><text><SENT sid="466" pm="."><plain>(PDF) </plain></SENT>
</text></p></caption><media xlink:href="pone.0211756.s008.pdf"><caption><p><text><SENT sid="467" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0211756.s009"><label>S5 Fig</label><caption><title><text><SENT sid="468" pm="."><plain>Tertiary structures of top-ranked and enriched aptamers. </plain></SENT>
</text></title><p><text><SENT sid="469" pm="."><plain>Here, we show the N40 variable region of the aptamers, including the flanking 5’ (TAGGGAAGAGAAGGACATATGAT) and 3’ (TTGACTAGTACATGACCACTTGA) regions. </plain></SENT>
<SENT sid="470" pm="."><plain>Secondary structures were predicted considering the flanking regions, at 25oC, 100 mM Na+, and 3 mM Mg+2, using the Mfold web server. A 3-D ssRNA model was built through RNAcomposer server and using VMD molefacture and PSF builder the ssRNA structure was transformed into a ssDNA structure. </plain></SENT>
<SENT sid="472" pm="."><plain>Finally, the structure was minimized using Namd software. </plain></SENT>
</text></p><p><text><SENT sid="473" pm="."><plain>(PDF) </plain></SENT>
</text></p></caption><media xlink:href="pone.0211756.s009.pdf"><caption><p><text><SENT sid="474" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0211756.s010"><label>S6 Fig</label><caption><title><text><SENT sid="475" pm="."><plain>Averaged ZDOCK scores for the PfR6–HMG-box Pf complex. </plain></SENT>
</text></title><p><text><SENT sid="476" pm="."><plain>Binding of the selected aptamers 3D ssDNA structures to the HMG-box Pf were predicted using ZDOCK server. A) The ZDOCK score of 2,000 iterations were averaged using Graphpad Prism 7.02. </plain></SENT>
<SENT sid="478" pm="."><plain>B) Highest ZDOCK score of each aptamer. </plain></SENT>
</text></p><p><text><SENT sid="479" pm="."><plain>(PDF) </plain></SENT>
</text></p></caption><media xlink:href="pone.0211756.s010.pdf"><caption><p><text><SENT sid="480" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0211756.s011"><label>S1 Table</label><caption><title><text><SENT sid="481" pm="."><plain>Potential biomarkers for Plasmodium falciparum infection as proposed by the algorithm in Fig 1. </plain></SENT>
</text></title><p><text><SENT sid="482" pm="."><plain>(PDF) </plain></SENT>
</text></p></caption><media xlink:href="pone.0211756.s011.pdf"><caption><p><text><SENT sid="483" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0211756.s012"><label>S2 Table</label><caption><title><text><SENT sid="484" pm="."><plain>Reaction conditions used in each SELEX cycle. </plain></SENT>
</text></title><p><text><SENT sid="485" pm="."><plain>(PDF) </plain></SENT>
</text></p></caption><media xlink:href="pone.0211756.s012.pdf"><caption><p><text><SENT sid="486" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><p><text4fund><text><SENT sid="487" pm="."><plain>We are very thankful to Andrey Konevega and Nanotemper RUS for kindly providing access to the Microscale Thermophoresis technology. </plain></SENT>
<SENT sid="488" pm="."><plain>We are also thankful to Luis Carlos Poggi for expert support on the artwork and graphics. </plain></SENT>
</text></text4fund></p></ack></SecTag><SecTag type="REF"><ref-list><title>References</title><ref id="pone.0211756.ref001"><text><SENT sid="489" pm="."><plain>1World Health Organization. </plain></SENT>
<SENT sid="490" pm="."><plain>World malaria report 2018 [Internet]. </plain></SENT>
<SENT sid="491" pm="."><plain>2018 Nov pp. </plain></SENT>
<SENT sid="492" pm="."><plain>1–210. </plain></SENT>
</text></ref><ref id="pone.0211756.ref002"><text><SENT sid="493" pm="."><plain>2WongsrichanalaiC, BarcusMJ, MuthS, SutamihardjaA, WernsdorferWH. A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT). Am J Trop Med Hyg. 2007;77: 119–127. <?supplied-pmid 18165483?>18165483 </plain></SENT>
</text></ref><ref id="pone.0211756.ref003"><text><SENT sid="494" pm="."><plain>3LiB, SunZ, LiX, LiX, WangH, ChenW, et al Performance of pfHRP2 versus pLDH antigen rapid diagnostic tests for the detection of Plasmodium falciparum: a systematic review and meta-analysis. Arch Med Sci. 2017;13: 541–549. 10.5114/aoms.2017.67279 <?supplied-pmid 28507567?>28507567 </plain></SENT>
</text></ref><ref id="pone.0211756.ref004"><text><SENT sid="495" pm="."><plain>4ChengQ, GattonML, BarnwellJ, ChiodiniP, McCarthyJ, BellD, et al Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: a review and recommendations for accurate reporting. Malar J. BioMed Central; 2014;13: 283 10.1186/1475-2875-13-283 <?supplied-pmid 25052298?>25052298 </plain></SENT>
</text></ref><ref id="pone.0211756.ref005"><text><SENT sid="496" pm="."><plain>5MenegonM, L'EpiscopiaM, NurahmedAM, TalhaAA, NourBYM, SeveriniC. Identification of Plasmodium falciparum isolates lacking histidine-rich protein 2 and 3 in Eritrea. Infect Genet Evol. 2017;55: 131–134. 10.1016/j.meegid.2017.09.004 <?supplied-pmid 28889944?>28889944 </plain></SENT>
</text></ref><ref id="pone.0211756.ref006"><text><SENT sid="497" pm="."><plain>6JainP, ChakmaB, PatraS, GoswamiP. Potential biomarkers and their applications for rapid and reliable detection of malaria. BioMed Research International. 2014;2014: 852645–20. 10.1155/2014/852645 <?supplied-pmid 24804253?>24804253 </plain></SENT>
</text></ref><ref id="pone.0211756.ref007"><text><SENT sid="498" pm="."><plain>7Le RochKG, JohnsonJR, FlorensL, ZhouY, SantrosyanA, GraingerM, et al Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle. Genome Res. 2004;14: 2308–2318. 10.1101/gr.2523904 <?supplied-pmid 15520293?>15520293 </plain></SENT>
</text></ref><ref id="pone.0211756.ref008"><text><SENT sid="499" pm="."><plain>8BozdechZ, MokS, HuG, ImwongM, JaideeA, RussellB, et al The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites. Proc Natl Acad Sci USA. 2008;105: 16290–16295. 10.1073/pnas.0807404105 <?supplied-pmid 18852452?>18852452 </plain></SENT>
</text></ref><ref id="pone.0211756.ref009"><text><SENT sid="500" pm="."><plain>9CaroF, AhyongV, BetegonM, DeRisiJL. Genome-wide regulatory dynamics of translation in the Plasmodium falciparum asexual blood stages. eLife. 2014;3: 568 10.7554/eLife.04106 <?supplied-pmid 25493618?>25493618 </plain></SENT>
</text></ref><ref id="pone.0211756.ref010"><text><SENT sid="501" pm="."><plain>10MichelAM, BaranovPV. Ribosome profiling: a Hi-Def monitor for protein synthesis at the genome-wide scale. Wiley Interdiscip Rev RNA. 2013;4: 473–490. 10.1002/wrna.1172 <?supplied-pmid 23696005?>23696005 </plain></SENT>
</text></ref><ref id="pone.0211756.ref011"><text><SENT sid="502" pm="."><plain>11ThiviyanathanV, GorensteinDG. Aptamers and the next generation of diagnostic reagents. </plain></SENT>
<SENT sid="503" pm="."><plain>Stastna M, Van Eyk JE, editors. Proteomics Clin Appl. 2012;6: 563–573. 10.1002/prca.201200042 <?supplied-pmid 23090891?>23090891 </plain></SENT>
</text></ref><ref id="pone.0211756.ref012"><text><SENT sid="504" pm="."><plain>12OliphantAR, BrandlCJ, StruhlK. Defining the sequence specificity of DNA-binding proteins by selecting binding sites from random-sequence oligonucleotides: analysis of yeast GCN4 protein. Molecular and Cellular Biology. 1989;9: 2944–2949. 10.1128/mcb.9.7.2944 <?supplied-pmid 2674675?>2674675 </plain></SENT>
</text></ref><ref id="pone.0211756.ref013"><text><SENT sid="505" pm="."><plain>13TuerkC, GoldL. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990;249: 505–510. <?supplied-pmid 2200121?>2200121 </plain></SENT>
</text></ref><ref id="pone.0211756.ref014"><text><SENT sid="506" pm="."><plain>14CheungY-W, KwokJ, LawAWL, WattRM, KotakaM, TannerJA. Structural basis for discriminatory recognition of Plasmodium lactate dehydrogenase by a DNA aptamer. Proc Natl Acad Sci USA. 2013;110: 15967–15972. 10.1073/pnas.1309538110 <?supplied-pmid 24043813?>24043813 </plain></SENT>
</text></ref><ref id="pone.0211756.ref015"><text><SENT sid="507" pm="."><plain>15SongH-O, LeeB, BhusalRP, ParkB, YuK, ChongC-K, et al Development of a novel fluorophore for real-time biomonitoring system. CarvalhoLH, editor. PLoS ONE. 2012;7: e48459 10.1371/journal.pone.0048459 <?supplied-pmid 23133635?>23133635 </plain></SENT>
</text></ref><ref id="pone.0211756.ref016"><text><SENT sid="508" pm="."><plain>16WangW-X, CheungY-W, DirkzwagerRM, WongW-C, TannerJA, LiH-W, et al Specific and sensitive detection of Plasmodium falciparum lactate dehydrogenase by DNA-scaffolded silver nanoclusters combined with an aptamer. Analyst. 2017;142: 800–807. 10.1039/c6an02417c <?supplied-pmid 28139780?>28139780 </plain></SENT>
</text></ref><ref id="pone.0211756.ref017"><text><SENT sid="509" pm="."><plain>17LeeS, ManjunathaDH, JeonW, BanC. Cationic surfactant-based colorimetric detection of Plasmodium lactate dehydrogenase, a biomarker for malaria, using the specific DNA aptamer. SchalligHDFH, editor. PLoS ONE. 2014;9: e100847 10.1371/journal.pone.0100847 <?supplied-pmid 24992632?>24992632 </plain></SENT>
</text></ref><ref id="pone.0211756.ref018"><text><SENT sid="510" pm="."><plain>18AurrecoecheaC, BrestelliJ, BrunkBP, DommerJ, FischerS, GajriaB, et al PlasmoDB: a functional genomic database for malaria parasites. Nucleic Acids Research. 2009;37: D539–43. 10.1093/nar/gkn814 <?supplied-pmid 18957442?>18957442 </plain></SENT>
</text></ref><ref id="pone.0211756.ref019"><text><SENT sid="511" pm="."><plain>19OttoTD, WilinskiD, AssefaS, KeaneTM, SarryLR, BöhmeU, et al New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. Molecular Microbiology. 2010;76: 12–24. 10.1111/j.1365-2958.2009.07026.x <?supplied-pmid 20141604?>20141604 </plain></SENT>
</text></ref><ref id="pone.0211756.ref020"><text><SENT sid="512" pm="."><plain>20GelinasAD, DaviesDR, JanjicN. Embracing proteins: structural themes in aptamer-protein complexes. Curr Opin Struct Biol. 2016;36: 122–132. 10.1016/j.sbi.2016.01.009 <?supplied-pmid 26919170?>26919170 </plain></SENT>
</text></ref><ref id="pone.0211756.ref021"><text><SENT sid="513" pm="."><plain>21ŠtrosM, LaunholtD, GrasserKD. The HMG-box: a versatile protein domain occurring in a wide variety of DNA-binding proteins. Cell Mol Life Sci. 2007;64: 2590–2606. 10.1007/s00018-007-7162-3 <?supplied-pmid 17599239?>17599239 </plain></SENT>
</text></ref><ref id="pone.0211756.ref022"><text><SENT sid="514" pm="."><plain>22SieversF, WilmA, DineenD, GibsonTJ, KarplusK, LiW, et al Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. 2011;7: 539–539. 10.1038/msb.2011.75 <?supplied-pmid 21988835?>21988835 </plain></SENT>
</text></ref><ref id="pone.0211756.ref023"><text><SENT sid="515" pm="."><plain>23MilonP, KonevegaAL, PeskeF, FabbrettiA, GualerziCO, RodninaMV. Transient kinetics, fluorescence, and FRET in studies of initiation of translation in bacteria. Meth Enzymol. 2007;430: 1–30. 10.1016/S0076-6879(07)30001-3 <?supplied-pmid 17913632?>17913632 </plain></SENT>
</text></ref><ref id="pone.0211756.ref024"><text><SENT sid="516" pm="."><plain>24LimTS, SchützeT, LehrachH, GlöklerJ, KonthurZ. Diversity visualization by endonuclease: a rapid assay to monitor diverse nucleotide libraries. Anal Biochem. 2011;411: 16–21. 10.1016/j.ab.2010.12.024 <?supplied-pmid 21185254?>21185254 </plain></SENT>
</text></ref><ref id="pone.0211756.ref025"><text><SENT sid="517" pm="."><plain>25AlamKK, ChangJL, BurkeDH. FASTAptamer: A Bioinformatic Toolkit for High-throughput Sequence Analysis of Combinatorial Selections. Mol Ther Nucleic Acids. 2015;4: e230 10.1038/mtna.2015.4 <?supplied-pmid 25734917?>25734917 </plain></SENT>
</text></ref><ref id="pone.0211756.ref026"><text><SENT sid="518" pm="."><plain>26BaileyTL, BodenM, BuskeFA, FrithM, GrantCE, ClementiL, et al MEME SUITE: tools for motif discovery and searching. Nucleic Acids Research. 2009;37: W202–8. 10.1093/nar/gkp335 <?supplied-pmid 19458158?>19458158 </plain></SENT>
</text></ref><ref id="pone.0211756.ref027"><text><SENT sid="519" pm="."><plain>27ZukerM. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Research. 2003;31: 3406–3415. 10.1093/nar/gkg595 <?supplied-pmid 12824337?>12824337 </plain></SENT>
</text></ref><ref id="pone.0211756.ref028"><text><SENT sid="520" pm="."><plain>28JeddiI, SaizL. Three-dimensional modeling of single stranded DNA hairpins for aptamer-based biosensors. Sci Rep. 2017;7: 1178 10.1038/s41598-017-01348-5 <?supplied-pmid 28446765?>28446765 </plain></SENT>
</text></ref><ref id="pone.0211756.ref029"><text><SENT sid="521" pm="."><plain>29PopendaM, SzachniukM, AntczakM, PurzyckaKJ, LukasiakP, BartolN, et al Automated 3D structure composition for large RNAs. Nucleic Acids Research. 2012;40: e112–e112. 10.1093/nar/gks339 <?supplied-pmid 22539264?>22539264 </plain></SENT>
</text></ref><ref id="pone.0211756.ref030"><text><SENT sid="522" pm="."><plain>30HumphreyW, DalkeA, SchultenK. VMD: visual molecular dynamics. J Mol Graph. 1996;14: 33–8–27–8. </plain></SENT>
</text></ref><ref id="pone.0211756.ref031"><text><SENT sid="523" pm="."><plain>31MacKerellAD, BanavaliN, FoloppeN. Development and current status of the CHARMM force field for nucleic acids. Biopolymers. 2000;56: 257–265. 10.1002/1097-0282(2000)56:4&lt;257::AID-BIP10029&gt;3.0.CO;2-W <?supplied-pmid 11754339?>11754339 </plain></SENT>
</text></ref><ref id="pone.0211756.ref032"><text><SENT sid="524" pm="."><plain>32PhillipsJC, BraunR, WangW, GumbartJ, TajkhorshidE, VillaE, et al Scalable molecular dynamics with NAMD. J Comput Chem. 2005;26: 1781–1802. 10.1002/jcc.20289 <?supplied-pmid 16222654?>16222654 </plain></SENT>
</text></ref><ref id="pone.0211756.ref033"><text><SENT sid="525" pm="."><plain>33WaterhouseA, BertoniM, BienertS, StuderG, TaurielloG, GumiennyR, et al SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Research. 2018;46: W296–W303. 10.1093/nar/gky427 <?supplied-pmid 29788355?>29788355 </plain></SENT>
</text></ref><ref id="pone.0211756.ref034"><text><SENT sid="526" pm="."><plain>34PierceBG, WieheK, HwangH, KimB-H, VrevenT, WengZ. ZDOCK server: interactive docking prediction of protein-protein complexes and symmetric multimers. Bioinformatics. 2014;30: 1771–1773. 10.1093/bioinformatics/btu097 <?supplied-pmid 24532726?>24532726 </plain></SENT>
</text></ref><ref id="pone.0211756.ref035"><text><SENT sid="527" pm="."><plain>35ChulluncuyR, EspicheC, NakamotoJA, FabbrettiA, MilonP. Conformational Response of 30S-bound IF3 to A-Site Binders Streptomycin and Kanamycin. Antibiotics (Basel). Multidisciplinary Digital Publishing Institute; 2016;5: 38 10.3390/antibiotics5040038 <?supplied-pmid 27983590?>27983590 </plain></SENT>
</text></ref><ref id="pone.0211756.ref036"><text><SENT sid="528" pm="."><plain>36MilonP, KonevegaAL, GualerziCO, RodninaMV. Kinetic checkpoint at a late step in translation initiation. Molecular Cell. 2008;30: 712–720. 10.1016/j.molcel.2008.04.014 <?supplied-pmid 18570874?>18570874 </plain></SENT>
</text></ref><ref id="pone.0211756.ref037"><text><SENT sid="529" pm="."><plain>37IngoliaNT, GhaemmaghamiS, NewmanJRS, WeissmanJS. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science. American Association for the Advancement of Science; 2009;324: 218–223. 10.1126/science.1168978 <?supplied-pmid 19213877?>19213877 </plain></SENT>
</text></ref><ref id="pone.0211756.ref038"><text><SENT sid="530" pm="."><plain>38KimH, CertaU, DöbeliH, JakobP, HolWG. Crystal structure of fructose-1,6-bisphosphate aldolase from the human malaria parasite Plasmodium falciparum. Biochemistry. 1998;37: 4388–4396. 10.1021/bi972233h <?supplied-pmid 9521758?>9521758 </plain></SENT>
</text></ref><ref id="pone.0211756.ref039"><text><SENT sid="531" pm="."><plain>39EllingtonAD, SzostakJW. In vitro selection of RNA molecules that bind specific ligands. Nature. 1990;346: 818–822. 10.1038/346818a0 <?supplied-pmid 1697402?>1697402 </plain></SENT>
</text></ref><ref id="pone.0211756.ref040"><text><SENT sid="532" pm="."><plain>40StoltenburgR, ReinemannC, StrehlitzB. FluMag-SELEX as an advantageous method for DNA aptamer selection. Anal Bioanal Chem. 2005;383: 83–91. 10.1007/s00216-005-3388-9 <?supplied-pmid 16052344?>16052344 </plain></SENT>
</text></ref><ref id="pone.0211756.ref041"><text><SENT sid="533" pm="."><plain>41SchneiderCA, RasbandWS, EliceiriKW. NIH Image to ImageJ: 25 years of image analysis. Nature Methods. 2012;9: 671–675. 10.1038/nmeth.2089 <?supplied-pmid 22930834?>22930834 </plain></SENT>
</text></ref><ref id="pone.0211756.ref042"><text><SENT sid="534" pm="."><plain>42DuhrS, BraunD. Why molecules move along a temperature gradient. Proceedings of the National Academy of Sciences. 2006;103: 19678–19682. 10.1073/pnas.0603873103 <?supplied-pmid 17164337?>17164337 </plain></SENT>
</text></ref><ref id="pone.0211756.ref043"><text><SENT sid="535" pm="."><plain>43DhontJKG, WiegandS, DuhrS, BraunD. Thermodiffusion of charged colloids: single-particle diffusion. Langmuir. 2007;23: 1674–1683. 10.1021/la062184m <?supplied-pmid 17279644?>17279644 </plain></SENT>
</text></ref><ref id="pone.0211756.ref044"><text><SENT sid="536" pm="."><plain>44BreitsprecherD, SchlinckN, WitteD, DuhrS, BaaskeP, SchubertT. Aptamer Binding Studies Using MicroScale Thermophoresis. Methods Mol Biol. New York, NY: Springer New York; 2016;1380: 99–111. 10.1007/978-1-4939-3197-2_8 <?supplied-pmid 26552819?>26552819 </plain></SENT>
</text></ref><ref id="pone.0211756.ref045"><text><SENT sid="537" pm="."><plain>45HianikT, OstatnáV, SonlajtnerovaM, GrmanI. Influence of ionic strength, pH and aptamer configuration for binding affinity to thrombin. Bioelectrochemistry. 2007;70: 127–133. 10.1016/j.bioelechem.2006.03.012 <?supplied-pmid 16725379?>16725379 </plain></SENT>
</text></ref><ref id="pone.0211756.ref046"><text><SENT sid="538" pm="."><plain>46BellD, PeelingRW, WHO-Regional Office for the Western Pacific/TDR. </plain></SENT>
<SENT sid="539" pm="."><plain>Evaluation of rapid diagnostic tests: malaria. </plain></SENT>
<SENT sid="540" pm="."><plain>Nature reviews. Microbiology. 2006 pp. S34–8. 10.1038/nrmicro152417034070 </plain></SENT>
</text></ref><ref id="pone.0211756.ref047"><text><SENT sid="541" pm="."><plain>47KaurH, SehgalR, KumarA, SehgalA, BansalD, SultanAA. Screening and identification of potential novel biomarker for diagnosis of complicated Plasmodium vivax malaria. Journal of Translational Medicine. </plain></SENT>
<SENT sid="542" pm="."><plain>BioMed Central; 2018;16: 42 10.1186/s12967-018-1646-9 <?supplied-pmid 30286756?>30286756 </plain></SENT>
</text></ref><ref id="pone.0211756.ref048"><text><SENT sid="543" pm="."><plain>48Meerstein-KesselL, van der LeeR, StoneW, LankeK, BakerDA, AlanoP, et al Probabilistic data integration identifies reliable gametocyte-specific proteins and transcripts in malaria parasites. Sci Rep. Nature Publishing Group; 2018;8: 410 10.1038/s41598-017-18840-7 <?supplied-pmid 29323249?>29323249 </plain></SENT>
</text></ref><ref id="pone.0211756.ref049"><text><SENT sid="544" pm="."><plain>49FrithK-A, FogelR, GoldringJPD, KrauseRGE, KhatiM, HoppeH, et al Towards development of aptamers that specifically bind to lactate dehydrogenase of Plasmodium falciparum through epitopic targeting. Malar J. 2018;17: 191 10.1186/s12936-018-2336-z <?supplied-pmid 29724225?>29724225 </plain></SENT>
</text></ref><ref id="pone.0211756.ref050"><text><SENT sid="545" pm="."><plain>50RousuJ, AgranoffDD, SodeindeO, Shawe-TaylorJ, Fernandez-ReyesD. Biomarker discovery by sparse canonical correlation analysis of complex clinical phenotypes of tuberculosis and malaria. PriceND, editor. PLoS Comput Biol. 2013;9: e1003018 10.1371/journal.pcbi.1003018 <?supplied-pmid 23637585?>23637585 </plain></SENT>
</text></ref><ref id="pone.0211756.ref051"><text><SENT sid="546" pm="."><plain>51KumarK, SingalA, RizviMMA, ChauhanVS. High mobility group box (HMGB) proteins of Plasmodium falciparum: DNA binding proteins with pro-inflammatory activity. Parasitol Int. 2008;57: 150–157. 10.1016/j.parint.2007.11.005 <?supplied-pmid 18234548?>18234548 </plain></SENT>
</text></ref><ref id="pone.0211756.ref052"><text><SENT sid="547" pm="."><plain>52KluneJR, DhuparR, CardinalJ, BilliarTR, TsungA. HMGB1: endogenous danger signaling. Mol Med. 2008;14: 476–484. 10.2119/2008-00034.Klune <?supplied-pmid 18431461?>18431461 </plain></SENT>
</text></ref><ref id="pone.0211756.ref053"><text><SENT sid="548" pm="."><plain>53BriquetS, Lawson-HogbanN, BoissonB, SoaresMP, PéronetR, SmithL, et al Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity. Infection and Immunity. 2015;83: 2771–2784. 10.1128/IAI.03129-14 <?supplied-pmid 25916985?>25916985 </plain></SENT>
</text></ref><ref id="pone.0211756.ref054"><text><SENT sid="549" pm="."><plain>54Le RochKG, ZhouY, BlairPL, GraingerM, MochJK, HaynesJD, et al Discovery of gene function by expression profiling of the malaria parasite life cycle. Science. 2003;301: 1503–1508. 10.1126/science.1087025 <?supplied-pmid 12893887?>12893887 </plain></SENT>
</text></ref><ref id="pone.0211756.ref055"><text><SENT sid="550" pm="."><plain>55BriquetS, BoschetC, GissotM, TissandiéE, SevillaE, FranetichJ-F, et al High-mobility-group box nuclear factors of Plasmodium falciparum. Eukaryotic Cell. 2006;5: 672–682. 10.1128/EC.5.4.672-682.2006 <?supplied-pmid 16607015?>16607015 </plain></SENT>
</text></ref><ref id="pone.0211756.ref056"><text><SENT sid="551" pm="."><plain>56NimjeeSM, WhiteRR, BeckerRC, SullengerBA. Aptamers as Therapeutics. Annu Rev Pharmacol Toxicol. 2017;57: 61–79. 10.1146/annurev-pharmtox-010716-104558 <?supplied-pmid 28061688?>28061688 </plain></SENT>
</text></ref><ref id="pone.0211756.ref057"><text><SENT sid="552" pm="."><plain>57CheungY-W, DirkzwagerRM, WongW-C, CardosoJ, D'Arc Neves CostaJ, TannerJA. Aptamer-mediated Plasmodium-specific diagnosis of malaria. Biochimie. 2018;145: 131–136. 10.1016/j.biochi.2017.10.017 <?supplied-pmid 29080831?>29080831 </plain></SENT>
</text></ref><ref id="pone.0211756.ref058"><text><SENT sid="553" pm="."><plain>58MirandaGF, FengL, ShiuSC-C, DirkzwagerRM, CheungY-W, TannerJA, et al Aptamer-Based Electrochemical Biosensor for Highly Sensitive and Selective Malaria Detection with Adjustable Dynamic Response Range and Reusability. Sensors &amp; Actuators: B Chemical. </plain></SENT>
<SENT sid="554" pm="."><plain>Elsevier B.V; 2017;: 1–23. 10.1016/j.snb.2017.07.117 </plain></SENT>
</text></ref><ref id="pone.0211756.ref059"><text><SENT sid="555" pm="."><plain>59HamaguchiN, EllingtonA, StantonM. Aptamer beacons for the direct detection of proteins. Anal Biochem. 2001;294: 126–131. 10.1006/abio.2001.5169 <?supplied-pmid 11444807?>11444807 </plain></SENT>
</text></ref><ref id="pone.0211756.ref060"><text><SENT sid="556" pm="."><plain>60DirkzwagerRM, KinghornAB, RichardsJS, TannerJA. APTEC: aptamer-tethered enzyme capture as a novel rapid diagnostic test for malaria. Chem Commun (Camb). 2015;51: 4697–4700. 10.1039/c5cc00438a <?supplied-pmid 25692283?>25692283 </plain></SENT>
</text></ref><ref id="pone.0211756.ref061"><text><SENT sid="557" pm="."><plain>61FraserLA, KinghornAB, DirkzwagerRM, LiangS, CheungY-W, LimB, et al A portable microfluidic Aptamer-Tethered Enzyme Capture (APTEC) biosensor for malaria diagnosis. Biosensors and Bioelectronics. 2018;100: 591–596. 10.1016/j.bios.2017.10.001 <?supplied-pmid 29032164?>29032164 </plain></SENT>
</text></ref><ref id="pone.0211756.ref062"><text><SENT sid="558" pm="."><plain>62GawandeBN, RohloffJC, CarterJD, Carlowitz vonI, ZhangC, SchneiderDJ, et al Selection of DNA aptamers with two modified bases. Proc Natl Acad Sci USA. 2017;114: 2898–2903. 10.1073/pnas.1615475114 <?supplied-pmid 28265062?>28265062 </plain></SENT>
</text></ref><ref id="pone.0211756.ref063"><text><SENT sid="559" pm="."><plain>63AbeydeeraND, EgliM, CoxN, MercierK, CondeJN, PallanPS, et al Evoking picomolar binding in RNA by a single phosphorodithioate linkage. Nucleic Acids Research. 2016;44: 8052–8064. 10.1093/nar/gkw725 <?supplied-pmid 27566147?>27566147 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
